EP3062699A2 - Couveuse en mousse expansée utilisable pour le transport de patients - Google Patents
Couveuse en mousse expansée utilisable pour le transport de patientsInfo
- Publication number
- EP3062699A2 EP3062699A2 EP14859025.0A EP14859025A EP3062699A2 EP 3062699 A2 EP3062699 A2 EP 3062699A2 EP 14859025 A EP14859025 A EP 14859025A EP 3062699 A2 EP3062699 A2 EP 3062699A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- sound
- pti
- envelope
- mri
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002595 magnetic resonance imaging Methods 0.000 claims abstract description 176
- 239000006260 foam Substances 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims description 141
- 239000000463 material Substances 0.000 claims description 81
- 230000009467 reduction Effects 0.000 claims description 49
- 230000033001 locomotion Effects 0.000 claims description 38
- 230000007246 mechanism Effects 0.000 claims description 36
- 238000010438 heat treatment Methods 0.000 claims description 34
- 238000012544 monitoring process Methods 0.000 claims description 34
- 238000013022 venting Methods 0.000 claims description 34
- 230000005540 biological transmission Effects 0.000 claims description 32
- 238000001816 cooling Methods 0.000 claims description 24
- 230000001105 regulatory effect Effects 0.000 claims description 24
- 230000008859 change Effects 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000012780 transparent material Substances 0.000 claims description 21
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 18
- 238000003384 imaging method Methods 0.000 claims description 15
- 239000011358 absorbing material Substances 0.000 claims description 13
- 238000009792 diffusion process Methods 0.000 claims description 13
- 239000003063 flame retardant Substances 0.000 claims description 12
- 230000036541 health Effects 0.000 claims description 12
- 230000002441 reversible effect Effects 0.000 claims description 12
- 230000002745 absorbent Effects 0.000 claims description 11
- 239000002250 absorbent Substances 0.000 claims description 11
- 238000009413 insulation Methods 0.000 claims description 11
- 239000003566 sealing material Substances 0.000 claims description 10
- 230000006870 function Effects 0.000 claims description 9
- 229960000890 hydrocortisone Drugs 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 230000005672 electromagnetic field Effects 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 description 12
- -1 polypropylene Polymers 0.000 description 12
- 229910052718 tin Inorganic materials 0.000 description 10
- 229910008355 Si-Sn Inorganic materials 0.000 description 9
- 229910006453 Si—Sn Inorganic materials 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 229920000877 Melamine resin Polymers 0.000 description 6
- 238000010276 construction Methods 0.000 description 6
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 6
- 238000005192 partition Methods 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 239000012774 insulation material Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000005534 acoustic noise Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 230000001483 mobilizing effect Effects 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 230000029058 respiratory gaseous exchange Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000002592 echocardiography Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000008571 general function Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 239000007799 cork Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000010370 hearing loss Effects 0.000 description 2
- 231100000888 hearing loss Toxicity 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 239000011810 insulating material Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011490 mineral wool Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000010255 response to auditory stimulus Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000004557 technical material Substances 0.000 description 2
- 230000028016 temperature homeostasis Effects 0.000 description 2
- 238000007666 vacuum forming Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- SHRRVNVEOIKVSG-UHFFFAOYSA-N 1,1,2,2,3,3-hexabromocyclododecane Chemical compound BrC1(Br)CCCCCCCCCC(Br)(Br)C1(Br)Br SHRRVNVEOIKVSG-UHFFFAOYSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- BSYJHYLAMMJNRC-UHFFFAOYSA-N 2,4,4-trimethylpentan-2-ol Chemical compound CC(C)(C)CC(C)(C)O BSYJHYLAMMJNRC-UHFFFAOYSA-N 0.000 description 1
- VEORPZCZECFIRK-UHFFFAOYSA-N 3,3',5,5'-tetrabromobisphenol A Chemical compound C=1C(Br)=C(O)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(O)C(Br)=C1 VEORPZCZECFIRK-UHFFFAOYSA-N 0.000 description 1
- HLXHCNWEVQNNKA-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-2-amine Chemical compound COC1=CC=C2CC(N)CC2=C1 HLXHCNWEVQNNKA-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004114 Ammonium polyphosphate Substances 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 240000004792 Corchorus capsularis Species 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 101000701446 Homo sapiens Stanniocalcin-2 Proteins 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 229910008048 Si-S Inorganic materials 0.000 description 1
- 239000004965 Silica aerogel Substances 0.000 description 1
- 229920002323 Silicone foam Polymers 0.000 description 1
- 229910006336 Si—S Inorganic materials 0.000 description 1
- 102100030510 Stanniocalcin-2 Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 229920006331 Thermacol Polymers 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 241001123263 Zostera Species 0.000 description 1
- 239000012814 acoustic material Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019826 ammonium polyphosphate Nutrition 0.000 description 1
- 229920001276 ammonium polyphosphate Polymers 0.000 description 1
- ADCOVFLJGNWWNZ-UHFFFAOYSA-N antimony trioxide Inorganic materials O=[Sb]O[Sb]=O ADCOVFLJGNWWNZ-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000005474 detonation Methods 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000249 far-infrared magnetic resonance spectroscopy Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 230000009970 fire resistant effect Effects 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 229920005669 high impact polystyrene Polymers 0.000 description 1
- 239000004797 high-impact polystyrene Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- ZQKXQUJXLSSJCH-UHFFFAOYSA-N melamine cyanurate Chemical compound NC1=NC(N)=NC(N)=N1.O=C1NC(=O)NC(=O)N1 ZQKXQUJXLSSJCH-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000582 polyisocyanurate Polymers 0.000 description 1
- 239000011495 polyisocyanurate Substances 0.000 description 1
- 229920007790 polymethacrylimide foam Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920006327 polystyrene foam Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000013514 silicone foam Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G11/00—Baby-incubators; Couveuses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
- A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G11/00—Baby-incubators; Couveuses
- A61G11/009—Baby-incubators; Couveuses with hand insertion windows, e.g. in the walls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2200/00—Information related to the kind of patient or his position
- A61G2200/10—Type of patient
- A61G2200/14—Children
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2203/00—General characteristics of devices
- A61G2203/10—General characteristics of devices characterised by specific control means, e.g. for adjustment or steering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2203/00—General characteristics of devices
- A61G2203/70—General characteristics of devices with special adaptations, e.g. for safety or comfort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2210/00—Devices for specific treatment or diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2210/00—Devices for specific treatment or diagnosis
- A61G2210/50—Devices for specific treatment or diagnosis for radiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G2210/00—Devices for specific treatment or diagnosis
- A61G2210/90—Devices for specific treatment or diagnosis for heating
Definitions
- the present invention relates to equipment for MRI imaging of patients.
- the present invention pertains to provide an MRI safe patient transport incubator, with the technological means to maintain thermo-isolation, noise reduction and welfare of patients during MRI, and a standard of care protocol for maintaining patient thermoregulation.
- MRI technology is frequently used to diagnose patient health and for research purposes. During MRI, patients experience bodily temperature change, and exposure to high levels of noise up to 120dB and stress (as described in Wikipedia "MRI").
- WO 2008/137003 describes an acoustic noise attenuation system for MRI scanning.
- This system comprises a capsule having two ends and configured both to enclose the entire body of a subject undergoing a scanning procedure in an MRI scanner having an inner bore and to fit within the scanner bore. At least one end of the enclosure is fitted with acoustically sealed pathways or connectors for monitoring or communicating with the subject.
- the described capsule is constructed of individual layers separated by a plurality of air spaces, and acoustically absorptive material.
- the acoustic noise attenuation system is constructed in means designed especially to isolate noise and vibration, in a multiuse apparatus.
- the preferred embodiment design of the system includes two openings at least for the patient to be accessed, and it is not known how this arrangement would function in case of an immediate need.
- a patient transport incubator in which the envelope separating the patient from the environment is a dedicated thermo-regulation noise reducing enclosure, and as such includes a thickened envelope made of MRI safe thermo-isolating noise reducing foam. Furthermore there is a need for a one time use, disposable envelope in order to maintain a sterile patient environment.
- the patient transport incubator of the present invention will allow easy access in a single step to the patient within.
- the envelope comprising MRI safe foam will limit patient movements resulting in better quality imaging, and less need to repeat process.
- the present invention provides a patient transport incubator (PTI) suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam.
- the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening;
- the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (c) the opening is adapted by means of size and shape to allow passage of a handler's hand.
- the envelope is configured to separate the patient tissues from coming into contact with the MRI bore;
- the envelope shape is selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and,
- the envelope is defined by means of size and shape to enable the placement of the patient's body such that the body does not form electrically conducting loops.
- the PTI as described above, comprising an envelope, wherein the envelope is configured to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof. It is another object of the current invention to disclose the PTI as described above, wherein at least one reversibly connectable module is connectable at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a predefined sound characteristic selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- the envelope further comprises at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, and any combination thereof, configured to change the sound signature reaching the patient.
- the envelope comprises at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value , STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - . . . dSn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- TRV temperature regulating vent
- the present invention provides a method of magnetic resonance imaging of patients comprising steps of: (a) obtaining a patient transport incubator (PTI) suitable for MRI device having an open bore; the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam; (b) placing the patient into the enveloped inner volume; and, (c) introducing the PTI into the MRI open bore and imaging.
- PTI patient transport incubator
- the present invention provides a method of manufacturing a patient transport incubator (PTI) suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore;
- at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam, comprising steps of: (a) defining dimensions of inner volume to accommodate the patient; (b) defining dimension adapted by shape and size for the envelope to be temporarily introduced within the MRI open bore; and, (c) forming envelope separating inner volume from its environment; wherein at least a portion of the envelope comprises MRI safe thermo-isolating noise reducing foam, separating the inner volume from its environment.
- the present invention provides a standard of care protocol for MRI of patients, comprising steps of: (a) obtaining a PTI suitable for magnetic resonance imaging device (MRD) with an open bore, the incubator comprising an inner volume having a first set of dimensions, the inner volume is adapted by means of shape and size to accommodating the patient, the inner volume further is covered by an envelope having a second set of dimensions, adapted by shape and size to be temporarily introduced within the open bore; when at least a portion of the envelope comprises MRI-safe thermo-isolating and noise reducing foam, confining the compartment from its environment; (b) placing the patient into enveloped inner volume; and, (c) introducing the incubator into MRI open bore and imaging; wherein at least one of the following is held true: (a) the sound pressure measured inside the PTI does not exceed a maximum level of 60 dB; and the sound level in the inner volume of the PTI compartment would be at least 10 dB lower than the sound level outside this compartment; (b) the sound pressure measured inside the PTI does not exceed a
- the average humidity levels of the inner volume of the PTI are maintained for the duration of MRI as medically predetermined by medical personal at levels of up to 85%; (1) the PTI will continue to be used safely in occurrence of a leakage of up to 200 ml deposited in the compartment of the PTI; (m) the PTI will remain stable when tilted 10° in normal use and when tilted 20° during transportation; (n) the PTI will not tip over when the force is 100 N or less; (o)the average number of patients MRI related fall incidents when utilizing the PTI is r times lower than the average of patients MRI related fall incidents; r is equal or greater than 1.05; (p) the average number of patient infections acquired that is MRI associated, when utilizing the PTI, is s times lower than the average number of infections acquired by
- the present invention provides a patient transport incubator (PTI) suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's cradle, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam.
- the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening;
- the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (c) the opening is adapted by means of size and shape to allow passage of a handler's hand.
- the envelope comprises a quick release mechanism enabling rapid access to a patient within the inner volume. It is another object of the current invention to disclose the PTI as described above, comprising at least a portion of at least partially transparent material, wherein the transparent material enables at least a part of the patient to be observed visually.
- the envelope is configured to separate patient tissues from coming into contact with the MRI bore;
- the envelope shape facing the inner volume is selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) the envelope is defined by means of size and shape to enable the placement of the patient's body such that the body does not form electrically conducting loops.
- a reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof.
- the envelope further comprises at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, and any combination thereof, configured to change the sound signature reaching the patient.
- the envelope comprises at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value , STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- the PTI as described above wherein each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - ... dSn, wherein dS of the PTI equals Si - Sn, and Si-S « ⁇ Si.
- TRV temperature regulating vent
- the present invention provides a method of magnetic resonance imaging of patients comprising steps of: (a) obtaining a patient transport incubator (PTI) suitable for MRI device having an open bore; the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's cradle, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam; (b) placing neonate into the neonate's cradle; (c) placing the neonate's cradle into the enveloped inner volume; and, (d) introducing the incubator into the MRI open bore and imaging.
- a patient transport incubator suitable for MRI device having an open bore
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-
- the present invention provides a method of manufacturing a patient transport incubator (PTI) suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's cradle, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore;
- at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam, comprising steps of: (a) defining dimensions of inner volume to accommodate at least a portion of the MRI-compatible neonate's cradle; (b) defining dimension adapted by shape and size for the envelope to be temporarily introduced within the MRI open bore when accommodating at least a portion of the MRI compatible neonate's cradle; and, (c) forming the envelope separating inner volume from its environment; wherein at least a portion of the envelope comprises MRI safe thermo-isolating noise
- Fig. 1 A is a schematic illustration of a PTI (100) in a cylindered embodiment
- Fig. IB is a schematic illustration of a cross section view of a PTI (100) in a cylindered embodiment, along the line of A in Fig 1;
- Fig. 2A is a schematic illustration of an infant transport incubator (100) in a rectangular embodiment;
- Fig. 2B is a schematic illustration of a cross section view of an infant transport incubator
- Fig. 2C is a schematic illustration of an embodiment of a detachable user interface (80);
- Fig. 2D is a schematic illustration of a cross section view of an infant transport incubator
- Fig. 2E is a schematic illustration of a cross section view of an infant transport incubator
- Fig. 3 is a schematic illustration of another embodiment of a PTI (100) that includes another embodiment of an opening (30), and attaching mechanism (42);
- Fig. 4A is a schematic illustration of another exemplary cylindrical embodiment arrangement of a PTI (100);
- Fig. 4B is a schematic illustration of a cross section view of a PTI (100) in cylindrical embodiment, along the line of A in Fig 4;
- Fig. 5 is a schematic diagram demonstrating the temperature across one section of the envelope of a PTI
- Fig. 6 is a schematic diagram demonstrating the sound level across one section of the envelope of the PTI
- Fig. 7 is a schematic diagram demonstrating the temperature as a function of time within the envelope of a PTI, and on the outside;
- Fig. 8 is a schematic illustration of a PTI (100) in cylindrical embodiment, including a temperature regulating vent (600);
- Fig. 9 is a schematic illustration of a PTI (100) in cylindrical embodiment, including a multilayered construction (300);
- Fig. 10 is a schematic illustration of a PTI (100) in a cylindrical embodiment encapsulating an neonate incubator attached to an MRI cart;
- Fig. 11 is a schematic illustration of a PTI (100) in a canopy embodiment encapsulating a neonate incubator attached to an MRI cart. DETAILED DESCRIPTION OF THE PREFERRED EMBOD EVENTS
- the essence of the present invention is to provide a patient transport incubator (PTI) suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam.
- the present invention provides a patient transport incubator (PTI) suitable for magnetic resonance imaging device (MRD) is provided.
- the MRD having an open bore
- the incubator comprising an inner volume, having a first set of dimensions, the inner volume is adapted by means of shape and size to accommodate at least a portion of MRI-compatible neonate's cradle, as depicted in patent 226488 IL, dated 21/5/2013 and is incorporated in its entirety;
- the inner volume further is covered by an envelope having a second set of dimensions, adapted by shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises thermo-isolating MRI safe, non- interfering noise reducing foam, separating the inner volume from its environment.
- thermo-isolating MRI-safe foam will increase the safety of MRI, as the body temperature of the patient will be maintained.
- the noise reducing qualities of the PTI will protect the patient's hearing and reduce noise related stress.
- the PTI will reduce stress related health complications and unnecessary repetitions of MRI.
- the term 'magnetic resonance imaging device' specifically applies hereinafter to any Magnetic Resonance Imaging (MRI) device, any Nuclear Magnetic Resonance (NMR) spectroscope, any Electron Spin Resonance (ESR) spectroscope, any Nuclear Quadruple Resonance (NQR), any Laser magnetic resonance device, any Quantum Rotational field magnetic resonance device (cyclotron), and any combination thereof.
- MRI Magnetic Resonance Imaging
- NMR Nuclear Magnetic Resonance
- ESR Electron Spin Resonance
- NQR Nuclear Quadruple Resonance
- Laser magnetic resonance device any Quantum Rotational field magnetic resonance device (cyclotron)
- cyclotron Quantum Rotational field magnetic resonance device
- the term also applies to any other analyzing and imaging instruments comprising a volume of interest, such as computerized tomography (CT), ultrasound (US) etc.
- CT computerized tomography
- US ultrasound
- the MRD hereby disclosed is optionally a portable MRI device, such as the ASPECT-MR
- MRI-safe interchangeably refers herein to any material that, when used in the MR environment, will present no additional risk to the patient and not significantly affect the quality of the diagnostic information.
- the material is completely non-magnetic, non- electrically conductive, and non-RF reactive, eliminating all of the primary potential threats during an MRI procedure.
- open bore interchangeably refers herein after to MRD's open bore and for C- shape MRD's open yolk .
- patient interchangeably refers herein after to a term selected from a group of: neonate, baby, infant, toddler, child, adolescent, adult, elderly, etc.; further this term refers to person or animal.
- handler interchangeably refers herein after to a term selected from a group of: medical personal, maintenance personal, chaperon and technician.
- foam interchangeably refers hereinafter to materials such as styrofoam® commercially available from The Dow Chemical Company, polystyrene foam, high-impact polystyrene, polybutadiene, polyurethane foam, polyvinyl chloride foam, polyimide foam, silicone foam, polymethacrylimide foam, polypropylene foam, polyethylene foam, syntactic foam, rubber, polybutadiene rubber, carbon, cellulose, starch, graphite, acrylonitrile, maleic anhydride, divinylbenzene, aerogel, silica aerogel, ceramics, polyisocyanurate, cementitious foam, glass, silica, etc.
- materials such as styrofoam® commercially available from The Dow Chemical Company, polystyrene foam, high-impact polystyrene, polybutadiene, polyurethane foam, polyvinyl chloride foam, polyimide foam, silicone foam, polymethacrylimide foam, polypropylene foam
- this foam is open cell, closed cell foam, and can contain micro-balloons of an additional material such as glass, carbon, epoxy, etc., or alternatively, the foam can be composite foam, these are acoustical foams that are made by layering different facings or foams together to create enhanced performance for specific application types. Additionally or alternatively, the foam can be porous, non-porous, at least partially flexible, rigid, liquid absorbent, lightweight,
- fire retardant materials interchangeably refers hereinafter to materials such as tetrabromobisphenol-a, decabromdiphenyl ether, hexabromcyclododecane, chloroparaffins, dedecachloro-pentacyclooctadecadiene, diphenyl phosphate, triaryl phosphates, metal phosphinates, 9, 10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide, trischloropropyl phosphate, ammonium polyphosphate, red phosphorous, melamine, melamine cyanurate, melamine polyphosphate, melamine polyzinc, melamine polyaluminum, phosphates, melamine-based HALS (Hindered Amine Light Stabilizer), intumescent flame retardant systems, metal hydroxides, zinc compounds antimony trioxide, expandable graphite, organo- layered silicates, natural oil polyols etc
- transparent material interchangeably refers hereinafter to materials such as, poly-methyl methacrylate, thermoplastic polyurethane, polyethylene, polyethylene terephthalate, isophthalic acid modified polyethylene terephthalate, glycol modified polyethylene terephthalate, polypropylene, polystyrene, acrylic, polyacetate, cellulose acetate, polycarbonate, nylon, glass, polyvinyl chloride etc.
- compartment interchangeably refers herein to the inner volume of the infant incubator defined by means of shape and size.
- mattress interchangeably refers herein to the part of the inner envelope on which the patient is placed.
- CPU-central processing unit interchangeably refers hereinafter to the hardware within a computer that carries out the instructions of a computer program by performing the basic arithmetical, logical, and input/output operations of the system.
- sensing equipment interchangeably refers hereinafter to any device that receives a signal or stimulus (heat, pressure, light, motion, sound, humidity etc.) and responds to it in a distinctive manner.
- visual indicators interchangeably refers hereinafter to a representation of light in the visible light range of about 380 nanometers to about 740 nm. More generally the terms refer to any light within the visible range that will be noticeable by the user of the invention (light, flashing light, flickering light, blinking light, change of spectrum of colors of light etc.).
- audible indicators interchangeably refers hereinafter to a representation of sound, typically as an electrical voltage. Audible indicators have frequencies in the audio frequency range of roughly 20 to 20,000 Hz (the limits of human hearing). Audible indicators may be synthesized directly, or may originate at a transducer such as a microphone, musical instrument pickup, phonograph cartridge, or tape head.
- Audible indicators interchangeably refers hereinafter to a physical movement of at least a portion of the user interface, which is noticeable to the user (shaking, vibrating, quivering, etc.).
- quick release mechanism interchangeably refers hereinafter to a mechanism such as quick release: fastener, draw latch, latch, lock, belt, bolt, grip, bar, bond, clamp, clasp, connection, fixture, link, hook, hasp, buckle, harness, clip, snap, pin, peg, grapnel, etc., that facilitates fast disconnecting of incubator envelope parts that will enable the quick / immediate release of the patient.
- the term “ergonomic” interchangeably refers hereinafter to the design of the incubator configured to minimize discomfort of the user, handler or both.
- the incubator is designed in a manner that fits the patient's body and its cognitive abilities. More specifically this term relates to the placement within the inner volume of the incubator to be fitting by means of size, shape, surface properties, sound transmission, light transmission, etc., to be appropriate for maximizing the well-being of the patient.
- This term further relates to the human interface of the incubator designed for the handler, parts such as the user interface, open and close mechanisms, overall size and shape, connections to other equipment, etc., are all designed in a manner that takes into consideration human factors.
- lock mechanism interchangeably refers hereinafter to a mechanism that connects the incubator to other equipment such as: patient tray, gurney, patient bed, trolley, push chair, wheelchair, perambulator, table, bar, bench, board, counter, desk, stand, console, trolley, etc.
- medical equipment interchangeably refers hereinafter to all devices, tubes, connectors, wires, liquid carriers, needles, sensors, etc., that are used by medical staff in association with the patient. This medical equipment is used for various purposes such as life support, MRI contras solution injection, monitoring of cardio and breathing rates, etc.
- electrical equipment interchangeably refers hereinafter to all devices powered by electricity from any source such as alternating current (AC), direct current (DC) or both. Further this current is supplied internally, externally or both.
- AC alternating current
- DC direct current
- the term “user interface” interchangeably refers hereinafter to at least one defined area in which the user interacts with the incubator. This area harbors: passage for medical equipment, display, CPU, alarm system, monitoring system, power supply, open mechanism, close mechanism, indicators, etc.
- the user interface is designed for the handler, user or both.
- module interchangeably refers hereinafter to a structurally independent part, able to be connected and detached from incubator. This module is connected itself or by another element in its contour, embedded, integrated, placed, interconnected, housed, contained, etc. to the incubator.
- user interface module interchangeably refers hereinafter to a module that organizes at least one of the elements in which the handler or user interact with.
- venting module interchangeably refers hereinafter to a module that circulates air and distributes it either evenly or in a defined direction. More specifically the term relates to a fan, a jet, a blower, a compressor, a pump, etc.
- heating/cooling module interchangeably refers hereinafter to a module that controls the temperature either by heating or by cooling or by doing both. More specifically the term relates to an air conditioned system, an infrared heater, a water/oil -heated radiator, a coiled heater, an open coil air heater, a round open coil air heater, a convection heater, straight or formed tubular heaters, a quartz tube air heater, a capacitor-type heater, a Pelletier module, etc.
- predetermined values interchangeably refers hereinafter to medical values such as respiration, cardiac function, blood oxygenation, brain activity; environmental values such as temperature, humidity, 0 2; C0 2 , sound pressure levels, vibrations, drift, electricity, radio frequency; system values such data transfer, opened or closed state of incubator envelope, structural integrity of incubator, structural integrity of interconnected parts, general function of incubator.
- stress index of salivary Cortisol levels interchangeably refers hereinafter to stress evaluated by the measurement of Cortisol levels in the saliva.
- medical facility interchangeably refers hereinafter to any facility providing medical services such as medical care, medical testing, laboratory, etc.
- connection in reference to the PTI parts and modules, interchangeably refers hereinafter to any contact, relation, association, integration, interconnection, joining etc., of the PTI parts and modules to one another and to third party.
- human hearing interchangeably refers herein to any sound received by the human ear, with the typical frequency range for normal hearing being between 20-Hz to 20,000-Hz.
- the logarithmic decibel scale, dB is used when referring to sound power.
- decibels or “dB”, interchangeably refers herein to the unit used to express the ratio between two values of such as an amplitude. If sound power ratios are x and amplitude ratios Vx then dB equivalents 10 loglO x.
- ⁇ measured amplitude
- a 0 reference amplitude
- a change in power ratio by a factor of 10 is a change of 10 dB.
- the decibel is commonly used in acoustics as a unit of sound pressure, for a reference pressure of 20 micropascals in air and 1 micropascal in water.
- the reference pressure in air is set at the typical threshold of perception of an average human and there are common comparisons used to illustrate different levels of sound pressure.
- Sound pressure is a field quantity, therefore the field version of the unit definition is used:
- ? re f is equal to the standard reference sound pressure level of 20 micropascals in air or 1 micropascal in water.
- the smallest audible sound is 0 dB.
- Near total silence - 0 dB A whisper - about 15 dB
- Normal conversation -about 40-60 dB A lawnmower - 90 dB about
- a car horn -about 110 dB A rock concert or a jet engine - about 110-150 dB
- a gunshot or firecracker - 140 dB It is known in the art that any sound above 85 dB can cause hearing loss, and the loss is related both to the power of the sound as well as the length of exposure. Eight hours of 90-dB sound can cause damage to your ears; any exposure to 140-dB sound causes immediate damage (and causes actual pain).
- the PTI is configured to maintain the sound levels at 45 dB or lower within the inner volume.
- sound interchangeably refers herein to any audible acoustic waves, as depicted in Wikipedia, sound is a vibration that propagates as a typically audible mechanical wave of pressure and displacement, through a medium such as air or water, when intercepted by any human, animal or any mechanical device or receiver. It is in the scope of the present invention that sound can be characterized by at least one of the following parameters: sound levels (can be measured in as sound pressure or in decibels [dB], overtone composition, reverberations, sound frequency [Hz], sound wavelength [feet or meters], tone, sound wave amplitude, sound wave velocity [meters per sec.
- noise reduction is any desired change in at least one characteristic of the sound signature of the environment.
- wave shape is the actual shape of the wave.
- Some different types of waves are: sine waves, trapezoid waves, square waves, triangle waves, saw tooth waves, curved waves, linear waves and any combination thereof. It is the unique combination of the fundamental wave and the harmonics that gives a sound its timbre (the tone color, or the quality, of a sound). Timbre is also defined by the sound envelope.
- the Envelope is kind of a combination of amplitude and wavelength - it describes the individual parts of a sound, broken down into ADSR (Attack, Decay, Sustain, Release).
- the sound wave of the sound signature can be harmonic or non-harmonic. Additionally or alternatively the waves are of the same or different harmonics levels.
- sound wave phase refers herein to the time relationship between 2 waves.
- In- Phase - the waves are working together; (compression and rarefaction occur in both waves at the same time.) This increases the amplitude. If 2 waves are totally in-phase, then amplitude is increased by 3 dB.
- the envelope foam provides noise reducing qualities by allowing a different sound signature to enter the inner volume of the incubator than the sound generated by any noise generator in the environment.
- the envelope can completely attenuate the sound generated by the noise generator such that it is not auditable within the limits of the human hearing within said inner volume, additionally or alternatively, the sound can be attenuated partially, completely, or attenuated in at least one of the sound characteristics, therefore creating a new sound signature.
- the term "noise” interchangeably refers herein to any unwanted sound defined in terms of frequency spectrum (in Hz), intensity (in dB), and time duration.
- the sound is also defined by its sound signature. Noise can be steady-state, intermittent, impulsive, or explosive.
- Transient hearing loss may occur following exposure to loud noise, resulting in a temporary threshold shift (i.e., a shift in the audible threshold).
- This term further includes harmonious and/ or non- harmonious sounds, intended and/ or unintended such as: a melody, tapping, banging, chirping, squeaking, blast, buzz, cacophony, clamor, commotion, crash, echo, cry, explosion, roar, babel, bang, bellow, blare, boom, caterwauling, clang, clatter, detonation, din, discord, disquiet, disquietude, drumming, eruption, jangle, lamentation, outcry, pandemonium, peal, racket, knocking, shot, shouting, squawk, stridency, thud, uproar, yell, music, or any combination thereof including a single or plurality of each.
- Noise tends to be enhanced by decreases in section thickness, field of view, repetition time, and echo time.
- noise characteristics have a spatial dependence.
- noise levels can vary by as much as 10 dB as a function of patient position within a defined space such as the bore of a magnetic resonance system or within an incubator.
- the presence and size of the patient may also affect the level of acoustic noise.
- Airborne sound travels through the air and can transmit through a material, assembly or partition. Sound can also pass under doorways, through ventilation, over, under, around, and through obstructions. When sound reaches a room where it is unwanted, it becomes noise. Further, noise can be prolonged and multiplied by reverberations and reflections.
- the noise can originate from such as: a medical device operation, a scanning device, an incubator in communication with a motor, noise derived of an attached medical device, life support equipment, a venting mechanism, a thermo regulating system, an air filtering system, a humidifier, rapid alterations of currents within magnetic resonance coils, an external alarm, external speech sounds, closing or opening of the incubator, handling of equipment in the incubator vicinity, and etc.
- the foam is provided as a passive sound absorptive material, having at least a portion of sound energy dissipated within the medium itself as sound travels through it.
- Absorbing materials can be such as porous materials commonly formed of matted or spun fibers. Common porous absorbers allow air to flow into a cellular structure where sound energy is converted to heat. These may include a thick layer of cloth or carpet, spray-applied cellulose, aerated plaster, fibrous mineral wool and glass fiber, open-cell foam, and felted or cast porous ceiling tile.
- additional layers of the same foam or another acoustic insulation material is used to provide noise attenuation, incorporated in connection with the incubator; from within, on top, bottom, side, front ,back, at least partly enveloping the incubator, along at least a portion of the incubator inner volume and etc.
- Resonators can also absorb sound, this is created by holes or slots connected to an enclosed volume of trapped air.
- the term "resonators” interchangeably refers herein to a structure configured to typically act to absorb sound in a narrow frequency range.
- Resonators include some perforated materials and materials that have openings (holes and slots). Such as a Helmholtz resonator, which has the shape of a bottle. The resonant frequency is governed by the size of the opening, the length of the neck and the volume of air trapped in the chamber.
- a PTI as described above is disclosed further comprising foam embedded with holes or slots configured to provide sound absorbing resonators.
- the envelope comprises at least one concave shape or slot configured to house at least one selected from a group consisting of: insulation material, sound diffuser, sound resonator, sound shield, sound baffle, sound reflector, sound absorbing material, sound absorber, and any combination thereof.
- panel absorbers are panel absorbers.
- panel absorbers are non-rigid, non-porous materials which are placed over an airspace that vibrates in a flexural mode in response to sound pressure exerted by adjacent air molecules for example thin wood paneling over framing, lightweight impervious ceilings and floors, glazing and other large surfaces capable of resonating in response to sound.
- An absorber is configured to reduce the acoustic noise by absorbing the sound energy, when sound waves collide with the absorber (as opposed to reflecting the energy); where at least part of the absorbed energy is transformed into heat or movement energy.
- absorptive surface treatments to the envelope, foam or both can help to eliminate both reverberation and reflection problems.
- the foam is provided as a mass barrier configured to at least partially prevent the transmission of noise to the incubator inner environment. It is further in the scope of the present invention that the foam is provided as a porous sound absorbing material.
- a PTI as described above is disclosed further comprising vibration damping and/ or vibration isolation means.
- The can be such as any flexible elements such as rubber, spring, cork or physical brake.
- Acoustic insulation material or “sound insulation padding” interchangeably refers herein to any material with the ability to absorb sound, act as a barrier of sound, or both.
- materials such as: cork, wool, cotton, Eel grass, fiber glass, glass wool, wood, paper, Cobalt Quilt, sugarcane, hydrated Calcium sulphate, POP, Coir, plastic, PVC, perforated metal, Mineral fiber board, or Micore, Thermocole, Polyurethane, Jute, Mylar film, melamine, rubber, rock wool, cellulose, polystyrene, polyethylene, polyester, any of these materials when recycled, and etc.
- the acoustic material can be in one or more forms such as a sheet, fabric, tile, blanket, foam, rug, carpet, drape, curtain, panel, board, any casted shape, rod, block, beads, straw like, gravel like particles, Fabric can be wrapped around substrates to create what is referred to as a "pre-fabricated panel", and any combination thereof.
- the insulation material can be at least partially constructed from Composite foams. Composite foams can meet more than one acoustical requirements at the same time such as providing both sound blocking and sound absorbing capabilities. These can be open or closed cell foams. Additionally or alternatively all the aforementioned materials can be at least partly porous. Additionally or alternatively, all the aforementioned materials can be combined with fire resistant materials. It is in the scope of the present invention that the MRI safe thermo regulating, noise reducing foam is an acoustical insulating material, and/ or is further embedded/ covered with acoustical insulating material.
- Base Traps interchangeably refers herein to acoustic energy absorbers which are designed to damp low frequency sound energy with the goal of attaining a flatter low frequency (LF) room response by reducing LF resonances in rooms. Similar to other acoustically absorptive devices, they function by turning sound energy into heat through friction.
- bass traps There are generally two types of bass traps: resonating absorbers and porous absorbers. By their nature resonating absorbers tend toward narrow band action [absorb only a narrow range of sound frequencies] and porous absorbers tend toward broadband action [absorbing sound all the way across the audible band - low, mid, and high frequencies], though both types can be altered to be either more narrow, or more broad in their absorptive action. Examples of resonating type bass traps include Helmholtz resonators, and devices based on diaphragmic elements or membranes which are free to vibrate in sympathy with the room's air when sound occurs.
- a PTI as described above wherein said envelope comprises a selected from a group consisting of at least one bass trap, at least one absorbing resonator, at least one porous resonator, at least one diffuser and any combination thereof.
- diffusion refers to the efficacy by which sound energy is spread evenly in a given environment.
- a perfectly diffusive sound space is, as defined in Wikipedia, one that has certain key acoustic properties which are the same anywhere in the space.
- a non-diffuse sound space would have considerably different reverberation time as the listener moved around the room. Spaces which are highly non- diffuse are ones where the acoustic absorption is unevenly distributed around the space, or where two different acoustic volumes are coupled.
- the diffusiveness of a sound field can be measured by taking reverberation time measurements at a large number of points in the room, then taking the standard deviation on these decay times. Small sound spaces generally have very poor diffusion characteristics at low frequencies due to room modes.
- diffusers are an excellent alternative or complement to sound absorption because they do not remove sound energy, but can be used to effectively reduce distinct echoes and reflections while still leaving a live sounding space.
- a diffusor will cause the sound energy to be radiated in many directions, hence leading to a more diffusive acoustic space.
- Diffusors can aid sound diffusion, but this is not why they are used in many cases; they are more often used to remove coloration and echoes.
- the term 'diffusers' also relates to MLS Diffusors, 1000Hz Quadratic-Residue Diffusor, Primitive-Root Diffusors, Optimized Diffusors, Two Dimensional ("Hemispherical”) Diffusors etc.
- sound baffle interchangeably refers herein to a construction or device which reduces the strength (level) of airborne sound, as measured in dB (decibels). Sound baffles are a fundamental tool of noise mitigation, for the practice of minimizing noise or reverberation. An important type of sound baffle is a noise barrier/ sound shield. Sound baffles are also applied to walls and ceilings in building interiors to absorb sound energy and thus lessen reverberation. These include, as non-limiting examples, wave baffles, fabric coated baffles, curtain baffles, panel baffles and etc.
- an incubator comprising an envelope fitted for housing a neonate, comprising at least one air flow opening, the opening comprising at least one selected from a group consisting of: a resonator, a sound baffle, a diffuser, a bass trap, a sound muffler, a sound shield, configured to attenuate sound.
- the envelope comprises volume having height represented by h, and is measured preferably in millimeters. The value of h can be constant or variable throughout the medical device. In at least a portion of this volume resonators and/or attenuators can be implemented. Further this volume can be filled with sound absorptive material situated around and /or within the perforations.
- sound shield refers herein after to any sound barriers or sound reflection panel, sound absorbing panel, screens, baffle, or any combination thereof, single or a plurality of, configured to lowering the sound reaching the patient.
- reverberation interchangeably refers herein to a prolongation of the sound in the room caused by continued multiple reflections is called reverberation. This can happen in an at least partially enclosed space during the time it takes a sound to become inaudible and stop emitting energy. When room surfaces are highly reflective, sound continues to reflect or reverberate. The effect of this condition is described as a live space with a long reverberation time. A high reverberation time will cause a build-up of the noise level in a space.
- reflection interchangeably refers herein to a phenomenon that sound reflects back from at least one surface or object before reaching the receiver. These reflections can have unwanted or even disastrous consequences. Reflective corners or peaked ceilings can create a "megaphone” effect potentially causing annoying reflections and loud spaces. Reflective parallel surfaces lend themselves to a unique acoustical problem called standing waves, creating a "fluttering" of sound between the two surfaces. The standing waves can produce natural resonances that can be heard as a pleasant sensation or an annoying one. Reflections can be attributed to the shape of the space as well as the material on the surfaces. Domes and concave surfaces cause reflections to be focused rather than dispersed which can cause annoying sound reflections.
- NRC Noise Reduction Coefficient
- STC Service Transmission Class
- STC is a number rating of the transmission loss properties of a material and/or product. It is a single-number rating of a material's or an assembly's ability to resist airborne sound transfer at the frequencies 125-4000 Hz. Substantially, this refers to a material's barrier ability qualities. In general, a material / product with higher STC rating blocks more noise from transmitting through a partition. STC is highly dependent on the construction of the partition. A partition's STC can be increased by: adding mass, increasing or adding air space, adding absorptive material within the partition, and likewise. A partition is given an STC rating by measuring its Transmission Loss over a range of 16 different frequencies between 125-4000 Hz. The STC rating does not assess the low frequency sound transfer. Doors, windows, walls, floors, etc. are tested to determine how much noise passes through.
- a patient transport incubator suitable for MRI device having an open bore;
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam.
- a PTI as defined above comprising an enveloped inner volume, wherein at least a portion of the envelope is integrated with fire retardant materials.
- a PTI as defined above is disclosed, wherein the envelope comprises at least one opening.
- a PTI as defined above comprising at least two connected parts, wherein the parts are connected by means such as hinge, joint, hook, link, bridge, clamp, bond, bracket, clasp, lock, snap, brace, grip, juncture, interweave, threading, etc.
- a PTI as defined above comprising an envelope with at least one open position and one closed position.
- a PTI as defined above is disclosed, wherein the open position is achieved by moving at least a part of the envelope relative to another part of the envelope that remain in a fixed position. This movement enables the envelope parts be to completely separate or remain connected in at least a portion of the envelope.
- a PTI as defined above wherein the connection between the envelope parts is defined by means of location, material and shape to isolate the inner volume of the envelope from the outside conditions selected from a group consisting of: temperature, humidity, sound, vibration, 0 2 concentration, C0 2 concentration and any combination thereof.
- a PTI as defined above wherein the envelope is formed in at least one of a plurality of shapes such as substantially cylindered, spherical, rectangular, polygonal, polymorphic, symmetrical, none symmetrical, concave, ergonomic, etc.
- a PTI as defined above is disclosed, wherein at least one of the following holds true: (a) the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening; (b) the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (c) the opening is adapted by means of size and shape to allow passage of a handler's hand.
- a PTI as defined above is disclosed, further comprising acoustical insulation material.
- a PTI as defined above comprising an envelope, wherein the envelope is configured for at least one open position for accommodating the patient, and at least one closed position configured to at least partially confine the patient within the inner volume.
- a PTI as defined above is disclosed, wherein the envelope is defined by means of size and shape to fit a specific predefined patient body position as defined by medical needs.
- a PTI as defined above wherein a mechanism attaches the patient transport incubator to the MRI bore;
- the attaching mechanism operates by: belting, screwing, hammering, fitting, sliding, tracking, latching, locking, joining, affixing, embedding, interweaving, clamping, coupling, locking, implanting, attaching, linking, adhering, stamping, covering, layering, connecting, interconnecting, hooking, inserting, engulfing etc.
- this attachment is a fast release mechanism, enabling fast extraction of the patient transport incubator from where it was attached.
- this attachment mechanism is attached to the incubator on one side, and to the MRD itself or other objects in the MRD open bore or such as patient support table, trolley, board, gurney, bed, etc., on the other side. This mechanism prevents tipping over and fall of the incubator.
- a PTI as defined above wherein the envelope comprises a quick release mechanism enabling rapid access to a patient within the inner volume.
- a PTI as defined above comprising at least a portion of at least partially transparent material, wherein the transparent material enables at least a part of the patient to be observed visually.
- a PTI as defined above is disclosed, wherein at least one of the following holds true: (a) the envelope separates patient tissues from coming into contact with the MRD bore; (b) the envelope shape is selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) the envelope is defined by means of size and shape to enable the placement of the patient's body such that the body does not form electrically conducting loops.
- a PTI as defined above comprising at least one sensor configured to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof.
- a PTI as defined above comprising sensing equipment wherein the equipment is connected embedded, integrated, layered, interconnected, fitted, placed, interweaved, adhered, implanted, nested, etc. to at least a portion of the PTI.
- a PTI as defined above comprising sensing equipment, further comprising at least one indicator, wherein the equipment responds to at least one signal by transmitting data to at least one indicator.
- a PTI as defined above comprising equipment from such as medical, electrical, transmitting, lighting, monitoring, heating, ventilating, viewing, etc., wherein the equipment is interconnected to the PTI.
- a PTI as defined above is disclosed, wherein the disclosed equipment is located at single or multiple locations of the PTI.
- a PTI as defined above wherein the indicator is selected from a group consisting of: audible indicators, visual indicators, sensible indicators, and any combination thereof.
- a PTI as defined above comprising an alarm system, wherein the alarm system is interconnected to the user interface.
- a PTI as defined above comprising an alarm system, wherein the alarm system responds to predetermined values.
- a PTI as defined above comprising alarm indicators, wherein the alarm indicator is selected from a group consisting of: audible indicators, visual indicators, sensible indicators and any combination thereof.
- a PTI as defined above comprising a CPU, wherein the CPU is interconnected to the user interface.
- a PTI as defined above is disclosed, wherein the CPU is interconnected to sensing equipment, medical equipment, power supply and any combination thereof.
- a PTI as defined above wherein the derivate data from the sensing equipment and electrical equipment is transferable to other devices selected from a group consisting of: medical, monitoring, CPU, user interface, control unit, indicators and any combination thereof.
- a PTI as defined above wherein the CPU receives, analyses, transfers and any combination thereof data received disclosed equipment.
- a PTI as defined above is disclosed, wherein the derivate data is transferable in a manner selected from a group consisting of: conducting wires, optical fibers, wireless communication channels and any combination thereof.
- a PTI as defined above comprising a thermo regulating vent, wherein this vent is specified in patent 61/893959 US dated 22/10/2013 and is incorporated herein in its entirety.
- a PTI as defined above comprising at least one user interface, wherein at least one user interfaces is located at a defined area of the incubator, so that it is accessible when the PTI is in the MRD open bore.
- a PTI as defined above comprising an envelope, wherein the envelope is configured to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof.
- a PTI as defined above wherein at least one reversibly connectable module is connectable at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a PTI as defined above is disclosed, wherein the PTI is configured to reduce the noise within the inner volume, in a predefined sound characteristic selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a PTI as defined above is disclosed, wherein the PTI is configured to reduce the noise by at least one selected from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a PTI as defined above is disclosed, wherein the envelope comprises at least one sound reflector configured to direct the noise to a selected from a group consisting of: at least one absorptive surface, at least one sound diffuser, at least one sound baffle, at least one reflective surface, at least one resonator, at least one sound shield, a location directed away from at least a portion of the patient, and any combination thereof.
- a PTI as defined above wherein the sound signature, is selected from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the neonate's life parameters, and any combination thereof.
- a PTI as defined above wherein the envelope further comprises at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, an active sound cancellation device, and any combination thereof, configured to change the sound signature reaching the patient.
- a PTI as defined above wherein the envelope comprises at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a PTI as defined above wherein at least a portion of the envelope comprises n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a PTI as defined above wherein each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value , STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a PTI as defined above wherein the n layers comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - . . . dSn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- NRC Noise Reduction Coefficient
- a PTI as defined above wherein the n layers comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - . . . dSn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ S 1 .
- STC Sound transmission class
- a PTI as defined above comprising: (a) a space, Si -n, between at least two the of n layers; (b) STCi (sound transmission class) value, measured for the layers i -n ; and, (c) reversible mobilization means, connected to at least one of the n layers, configured to mobilize at least one of the n layers, having a space Si -n between at least two of n layers such that a space Si -n,a i S , and STC 2 value measured for the layers i -n are provided; where Si -n ⁇ S ln,a and where STCi ⁇ STC 2 .
- a PTI as defined above wherein the envelope is configured to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of at least one selected from a group consisting of; absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, and any combination thereof.
- a PTI as defined above characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; the PTI further comprising in at least one of the ends, a temperature regulating vent (TRV); the TRV is adapted to stream air from the end towards the opposite end substantially along the axis; and is configured, by means of size and shape, to accommodate the patient in parallel to the axis; further wherein the TRV is a module selected from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof.
- TRV temperature regulating vent
- a standard of care protocol for MRI of patients comprising steps of: (a) obtaining a PTI suitable for magnetic resonance imaging device (MRD) with an open bore, the incubator comprising an inner volume having a first set of dimensions, the inner volume is adapted by means of shape and size to accommodating the patient, the inner volume further is covered by an envelope having a second set of dimensions, adapted by shape and size to be temporarily introduced within the open bore; when at least a portion of the envelope comprises MRI-safe thermo-isolating and noise reducing foam, (b) confining the compartment from its environment; (c) placing the patient into enveloped inner volume; and (d) introducing the incubator into MRI open bore and imaging; wherein at least one of the following is held true: (a) the sound pressure measured inside the PTI does not exceed a maximum level of 60 dB; and the sound level in the inner volume of the PTI compartment would be at least 10 dB lower than the sound level outside this compartment; (b) the sound pressure measured inside the P
- the average humidity levels of the inner volume of the PTI are maintained for the duration of MRI as medically predetermined by medical personal at levels of up to 85%; (1) the PTI will continue to be used safely in occurrence of a leakage of up to 200 ml deposited in the compartment of the PTI; (m) the PTI will remain stable when tilted 10° in normal use and when tilted 20° during transportation; (o) the PTI will not tip over when the force is 100 N or less; (p) the average number of patients MRI related fall incidents when utilizing the PTI is r times lower than the average of patients MRI related fall incidents; r is equal or greater than 1.05; (q) the average number of patient infections acquired that is MRI associated, when utilizing the PTI, is s times lower than the average number of infections acquired by
- a method of magnetic resonance imaging of patients comprising steps of: (a) obtaining a patient transport incubator (PTI) suitable for MRI device having an open bore; the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam; (b) placing the patient into the enveloped inner volume; and, (c) introducing the PTI into the MRI open bore and imaging.
- PTI patient transport incubator
- a method as defined above is disclosed, additionally comprising a step of obtaining the envelope further comprising at least a portion of fire retardant materials.
- a method as defined above is disclosed, additionally comprising a step of obtaining an inner volume envelope from a selected group varying in means of size and shape to fit the patient.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least one opening;
- a method as defined above additionally comprising at least one of the following steps: (a) obtaining the envelope in which the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening, and muffling at least partially the sound; (b) obtaining the envelope in which the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, passing at least a portion of the equipment form the environment to the inner volume; (c) obtaining the envelope in which the opening is adapted by means of size and shape to allow passage of a handler's hand, and reversibly passing a handler's hand through the opening.
- a method as defined above additionally comprising a step of configuring the envelope to providing at least one open position for accommodating the patient, and at least one closed position for to at least partially confining the patient within the inner volume, and accommodating or confining the patient.
- a method as defined above is disclosed, additionally comprising a step of securing configured closed position of the envelope.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising a quick release mechanism enabling rapid access to a patient within the inner volume, and operating the quick release mechanism.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least a portion of at least partially transparent material, wherein the transparent material enables at least a part of the patient to be observed visually, and viewing the patient.
- a method as defined above additionally comprising at least one of the following steps: (a) obtaining the envelope further configured to separating patient tissues from coming into contact with the MRD bore; (b) obtaining the envelope further comprising the inner volume facing shape selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) obtaining the envelope further defined by means of size and shape for enabling the placement of the patient's body such that the body does not form electrically conducting loops.
- a method as defined above additionally comprising a step of placing the patient in a compartment fit by dimensions of size and shape to accommodate and restrict movements of the patient.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least one sensor configured to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof, and sensing by the sensor.
- a method as defined above is disclosed, additionally comprising a step of receiving input from user interface, enabling surveillance of the patient.
- a method as defined above is disclosed, additionally comprising a step of coupling medical equipment to the incubator.
- a method as defined above additionally comprising a step of obtaining the envelope further configured to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof, and reversibly connect at least one aid module.
- a reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof, and reversibly connect at least one aid module.
- a method as defined above additionally comprising a step of connecting at least one reversibly connectable module at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of securing the incubator to defined patient location at MRD inner bore.
- a method as defined above is disclosed, additionally comprising a step of disposing at least a part of the incubator, following the end of use.
- a method as defined above additionally comprising a step of configuring the PTI to reduce the noise within the inner volume, in a predefined sound characteristic selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a method as defined above additionally comprising a step of reducing the noise within the inner volume, by at least one selected from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a method as defined above additionally comprising a step of changing at least one sound characteristic reaching the inner volume from the environment , selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof, thereby generating at least one sound signature.
- a method as defined above additionally comprising a step of selecting the sound signature from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the neonate's life parameters, and any combination thereof.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, an active sound cancellation device, and any combination thereof, configured to change the sound signature reaching the patient.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a method as defined above additionally comprising a step of obtaining the envelope in which at least a portion comprising n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a method as defined above additionally comprising a step of obtaining the envelope comprising n layers, each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further selecting each the layer comprising equal or different the NRC value, STC value, or both, for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a method as defined above additionally comprising a step of obtaining the envelope comprising the n layers further comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- NRC Noise Reduction Coefficient
- a method as defined above additionally comprising a step of obtaining the envelope comprising the n layers further comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ S 1 .
- STC Sound transmission class
- a method as defined above additionally comprising a step of obtaining the envelope further comprising: (a) a space, Si -n, between at least two the of n layers; (b) STCi (sound transmission class) value, measured for the layers i -n ; and, (c) reversible mobilization means, connected to at least one of the n layers, configured to mobilize at least one of the n layers, having a space Si -n between at least two of n layers such that a space S ⁇ a i S , and STC 2 value measured for the layers i -n are provided; where Si -n ⁇ Si n;a and where STCi ⁇ STC 2 , and reversibly mobilizing at least one layers.
- a method as defined above additionally comprising a step of obtaining the envelope further configured to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of utilizing at least one selected from a group consisting of: absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, and any combination thereof.
- a method as defined above additionally comprising the following steps: (a) obtaining the envelope further characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; the PTI further comprising in at least one of the ends, a temperature regulating vent (TRV); the TRV is adapted to stream air from the end towards the opposite end substantially along the axis; and is configured, by means of size and shape, to accommodate the patient in parallel to the axis; (b) selecting the TRV from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof; and, (c) operating the TRV, thereby preforming at least one of the following: venting, heating, cooling, filtering, humidifying, the air within the inner volume.
- TRV temperature regulating vent
- a method of manufacturing a patient transport incubator (PTI) suitable for MRI device having an open bore comprising an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate a patient, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam, comprising steps of: (a) defining dimensions of inner volume to accommodate the patient; (b) defining dimension adapted by shape and size for the envelope to be temporarily introduced within the MRI open bore; and (c) forming envelope separating inner volume from its environment; wherein at least a portion of the envelope comprises MRI safe thermo-isolating noise reducing foam, separating the inner volume from its environment.
- MRI safe thermo-isolating and noise reducing foam comprising steps of: (a) defining dimensions of inner volume to accommodate the patient; (b) defining dimension adapted by shape and size for the envelope to be temporarily
- a method as defined above is disclosed, additionally comprising a step of integrating at least a portion of the foam with fire retardant materials.
- a method as defined above is disclosed, additionally comprising a step of connecting at least two parts in order to form the envelope separating inner volume from its environment.
- a method as defined above is disclosed, additionally comprising a step of forming at least a portion of the envelope in a multi-layer construction.
- a method as defined above is disclosed, additionally comprising a step of defining a plurality of dimensions for the inner volume to accommodate various size and shape patients.
- a method as defined above additionally comprising a step of defining dimensions of inner volume to accommodate the patient forming at least a portion of the envelope in a shape creating an ergonomic patient space.
- a method as defined above is disclosed, additionally comprising a step of defining the dimensions of the envelope parts to be adapted to be ergonomic to the handler.
- a method as defined above is disclosed, additionally comprising a step of defining the dimensions of the envelope to be adapted to by means of size and shape to separates the patient's tissues from coming into contact with the MRD bore.
- a method as defined above is disclosed, additionally comprising a step of defining the dimensions of the envelope to be adapted to by means of size and shape to place the patient's body so that it does not form conducting loops.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope foam by means selected from a group consisting of: open-molding, closed-molding injection, vacuum forming, extruding, expanding, casting, stretching, sheet assembling, foaming, compositing and any combination thereof.
- a method as defined above additionally comprising a step of further forming at least a part of the envelope by surface modifications selected from a group consisting of: cleaning, sterilizing, smoothing, adding texture, coloring, covering, typing, adhering, puncturing, hammering, spraying, immersing and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of creating at least one opening in the incubator.
- a method as defined above additionally comprising a step of creating a space fitting by dimensions of size and shape to permit passage of equipment selected from a group of: medical, electrical, data transferring, sensing, ventilating, heating, viewing, monitoring and any combination thereof.
- a method as defined above additionally comprising a step of defining the connection areas between the envelope by means of location, material, shape and size to isolate the inner volume of the envelope from the outside conditions selected from a group consisting of: temperature, humidity, sound, vibration, 0 2 concentration, C0 2 concentration and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of forming the envelope comprising at least one opening.
- a method as defined above additionally comprising a step of, wherein at least one of the following holds true: (a) attaching at least one sound attenuating means configured to muffle the sound passing through the opening; (b) adapting the opening by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (c) configuring the opening by means of size and shape to allow passage of a handler's hand.
- a method as defined above additionally comprising a step of configuring the envelope for at least one open position for accommodating the MRI-compatible neonate's cradle, and at least one closed position for at least partially confining the MRI-compatible neonate's cradle within the inner volume.
- a method as defined above is disclosed, additionally comprising a step of integrating a quick release mechanism enabling rapid access to the patient within inner volume.
- a method as defined above is disclosed, additionally comprising a step of integrating a quick release mechanism enabling rapid release of the incubator from MRD open bore.
- a method as defined above is disclosed, additionally comprising a step of forming at least a portion of the envelope comprising at least partially transparent material, thereby enabling at least a part of the patient to be observed visually.
- a method as defined above is disclosed, additionally comprising a step of, wherein at least one of the following holds true: (a) forming the envelope configured to separating the patient tissues from coming into contact with the MRD bore; (b) selecting the envelope inner volume facing shape from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) defining the envelope by means of size and shape for enabling placement of the patient's body such that the body does not form electrically conducting loops.
- a method as defined above additionally comprising a step of attaching at least one sensor to the envelope, and configuring the sensor to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof.
- a method as defined above additionally comprising a step of configuring the envelope to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of constructing a separate module of user interface.
- a method as defined above is disclosed, additionally comprising a step of interconnecting user interface module to the incubator.
- a method as defined above additionally comprising a step of connecting sensing equipment from a selected group consisting of: temperature, humidity, gas concentrations, sound levels, vibrations, drift, light, respiration, cardiac function, blood oxygenation, neurological activity, electricity, radio frequency, data transfer, opened or closed state of incubator envelope, structural integrity of incubator, structural integrity of interconnected parts, general function of incubator and any combination thereof to the incubator.
- a method as defined above additionally comprising a step of connecting user interface to an item selected from a group consisting of: medical equipment, sensing equipment, electrical equipment, monitoring equipment, control unit, CPU, audio indicator, visual indicator, sensing indicator, alarm system, power supply and any combination thereof.
- a method as defined above additionally comprising a step of creating at least one reversible connection for at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a method as defined above additionally comprising a step of configuring the PTI to reduce the noise within the inner volume, in a predefined sound characteristic, and selecting the sound characteristic from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a method as defined above additionally comprising a step of selecting at least one noise parameter to be reduced from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a method as defined above additionally comprising a step of selecting at least one sound characteristic reaching the inner volume from the environment from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof, thereby generating at least one sound signature, to be changed by the PTI.
- a method as defined above additionally comprising a step of selecting the sound signature from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the patient's life parameters, and any combination thereof.
- a method as defined above additionally comprising a step of including at least one means selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, and any combination thereof, configured to changing the sound signature reaching the patient.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope comprising n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a method as defined above additionally comprising a step of forming each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value, STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a method as defined above additionally comprising a step of forming the n layers comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - ... dSn, wherein dS of the PTI equals
- NRC Noise Reduction Coefficient
- a method as defined above additionally comprising a step of forming the n layers comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - ...dS «, wherein dS of the PTI equals Si - Sn,
- STC Sound transmission class
- a method as defined above additionally comprising the following steps: (a) forming the envelope further comprising a space, Si -I1; between at least two the of n layers; (b) configuring at least one STCi (sound transmission class) value, measured for the layers i -n ; and, (c) connecting reversible mobilization means, connected to at least one of the n layers, configured to mobilizing at least one of the n layers, having a space Si -n between at least two of n layers such that a space Si- n, a is, and STC 2 value measured for the layers i -n are provided; where Si -n ⁇ Sin ,a and where
- a method as defined above additionally comprising a step of configuring the envelope to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of at least one selected from a group consisting of; absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, an active sound cancellation device and any combination thereof.
- a method as defined above additionally comprising the following steps: (a) forming the envelope further characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; (b) connecting a temperature regulating vent (TRV) to the PTI in at least one of the ends; (c) configuring the TRV to stream air from the end towards the opposite end substantially along the axis; (d) configuring the envelope, by means of size and shape, to accommodate the patient in parallel to the axis; and, (e) selecting the TRV from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof.
- TRV temperature regulating vent
- a patient transport incubator suitable for magnetic resonance imaging device (MRD) is provided.
- the MRD having an open bore, the incubator comprising an inner volume, having a first set of dimensions, the inner volume is adapted by means of shape and size to accommodate at least a portion of MRI-compatible neonate's cradle, as depicted in patent 226488 IL, dated 21/5/2013 and is incorporated in its entirety; the inner volume further is covered by an envelope having a second set of dimensions, adapted by shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises thermo-isolating MRI safe, non-interfering noise reducing foam, separating the inner volume from its environment.
- a PTI as defined above comprising at least two connected parts, wherein the parts are connected by means such as hinge, joint, hook, link, bridge, clamp, bond, bracket, clasp, lock, snap, brace, grip, juncture, interweave, threading, etc.
- a PTI as defined above wherein the open position is achieved by moving at least a part of the envelope relative to another part of the envelope that remains in a fixed position. This movement enables the envelope parts be to completely separate or remain connected in at least a portion of the envelope.
- a PTI as defined above is disclosed, wherein the connection between the envelope parts is defined by means of location, material and shape to better isolate the inner volume of the envelope from the outside conditions selected from a group consisting of: temperature, sound, vibration and any combination thereof.
- a PTI as defined above wherein the envelope is formed in at least one of a plurality of shapes such as cylindered, polygonal, polymorphic, symmetrical, none symmetrical, concave, ergonomic, etc.
- a PTI as defined above wherein a mechanism attaches the PTI to MRI-compatible neonate's cradle;
- the attaching mechanism operates by: belting, screwing, hammering, fitting, sliding, tracking, latching, locking, joining, affixing, embedding, interweaving, clamping, coupling, locking, implanting, attaching, linking, adhering, stamping, covering, layering, connecting, interconnecting, hooking, inserting, engulfing etc.
- this attachment is a fast release mechanism, enabling fast access to the MRI-compatible cradle within.
- a PTI as defined above comprising at least one user interface, wherein at least one user interfaces is located at a defined area of the incubator, so that it is accessible when the PTI is in the MRD open bore.
- a PTI as defined above comprising sensing equipment wherein the equipment is connected embedded, integrated, layered, interconnected, fitted, placed, interweaved, adhered, implanted, nested, etc. to at least a portion of the PTI.
- a PTI as defined above comprising sensing equipment, further comprising at least one indicator, wherein the equipment responds to at least one signal by transmitting data to at least one indicator.
- a PTI as defined above comprising equipment from such as medical, electrical, transmitting, lighting, monitoring, heating, ventilating, viewing, etc., wherein the equipment is interconnected to the PTI.
- a PTI as defined above is disclosed, wherein the disclosed equipment is located at single or multiple locations of the PTI.
- a PTI as defined above wherein the indicator is selected from a group consisting of: audible indicators, visual indicators, sensible indicators, and any combination thereof.
- a PTI as defined above comprising an alarm system, wherein the alarm system is interconnected to the user interface.
- a PTI as defined above comprising an alarm system, wherein the alarm system responds to predetermined values.
- a PTI as defined above comprising alarm indicators, wherein the alarm indicator is selected from a group consisting of: audible indicators, visual indicators, sensible indicators and any combination thereof.
- a PTI as defined above comprising a CPU, wherein the CPU is interconnected to the user interface.
- a PTI as defined above wherein the derivate data from the sensing equipment and electrical equipment is transferable to other devices selected from a group consisting of: medical, monitoring, CPU, user interface, control unit, indicators and any combination thereof.
- a PTI as defined above is disclosed, wherein the CPU receives, analyses, transfers and any combination thereof data received disclosed equipment.
- a PTI as defined above wherein the derivate data is transferable in a manner selected from a group consisting of: copper wires, optical fibers, wireless communication channels and any combination thereof.
- a PTI as defined above comprising an enveloped inner volume, wherein at least a portion of the envelope is integrated with fire retardant materials.
- a PTI as defined above is disclosed, wherein the envelope comprises at least one opening.
- a PTI as defined above wherein at least one of the following holds true: (a) the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening; (b) the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (c) the opening is adapted by means of size and shape to allow passage of a handler's hand.
- a PTI as defined above comprising an envelope, wherein the envelope is configured for at least one open position for accommodating the MRI-compatible neonate's cradle, and at least one closed position configured to at least partially confine the MRI-compatible neonate's cradle within the inner volume.
- a PTI as defined above wherein the envelope comprises a quick release mechanism enabling rapid access to a patient within the inner volume.
- a PTI as defined above comprising at least a portion of at least partially transparent material, wherein the transparent material enables at least a part of the patient to be observed visually.
- a PTI as defined above is disclosed, wherein at least one of the following holds true: (a) the envelope separates patient tissues from coming into contact with the MRD bore; (b) the envelope shape facing the inner volume is selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) the envelope is defined by means of size and shape to enable the placement of the patient's body such that the body does not form electrically conducting loops.
- a PTI as defined above comprising at least one sensor configured to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof.
- a PTI as defined above comprising an envelope, wherein the envelope is configured to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof.
- a PTI as defined above wherein at least one reversibly connectable module is connectable at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a PTI as defined above is disclosed, wherein the PTI is configured to reduce the noise within the inner volume, in a predefined sound characteristic selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a PTI as defined above is disclosed, wherein the PTI is configured to reduce the noise by at least one selected from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a PTI as defined above is disclosed, wherein the PTI is configured to change at least one sound characteristic reaching the inner volume from the environment, selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof, thereby generating at least one sound signature.
- a PTI as defined above wherein the sound signature, is selected from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the neonate's life parameters, and any combination thereof.
- a PTI as defined above wherein the envelope further comprises at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, and any combination thereof, configured to change the sound signature reaching the patient.
- a PTI as defined above wherein the envelope comprises at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a PTI as defined above wherein at least a portion of the envelope comprises n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a PTI as defined above wherein each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value , STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a PTI as defined above wherein the n layers comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- NRC Noise Reduction Coefficient
- a PTI as defined above wherein the n layers comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ S 1 .
- STC Sound transmission class
- a PTI as defined above comprising: (a) a space, Si -I1; between at least two the of n layers; (b) STCi (sound transmission class) value, measured for the layers i -n ; and, (c) reversible mobilization means, connected to at least one of the n layers, configured to mobilize at least one of the n layers, having a space Si -n between at least two of n layers such that a space Si -n,a i S , and STC2 value measured for the layers i -n are provided; where Si -n ⁇ S ln , a and where STCi ⁇ STC 2 .
- a PTI as defined above wherein the envelope is configured to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of at least one selected from a group consisting of; absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, an active sound cancellation device and any combination thereof.
- a PTI as defined above characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; the PTI further comprising in at least one of the ends, a temperature regulating vent (TRV); the TRV is adapted to stream air from the end towards the opposite end substantially along the axis; and is configured, by means of size and shape, to accommodate the patient in parallel to the axis; further wherein the TRV is a module selected from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof.
- TRV temperature regulating vent
- a magnetic resonance imaging of patients comprising steps of: (a) obtaining a patient transport incubator (PTI) suitable for MRI device having an open bore; the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's cradle, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam; (b) placing neonate into the neonate's cradle; (c) placing the neonate's cradle into the enveloped inner volume; and, (d) introducing the incubator into the MRI open bore and imaging.
- a patient transport incubator suitable for MRI device having an open bore
- the PTI comprises an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's
- a method as defined above is disclosed, additionally comprising a step of obtaining the envelope further comprising at least a portion of fire retardant materials.
- a method as defined above is disclosed, additionally comprising a step of obtaining the envelope further comprising at least one opening.
- a method as defined above additionally comprising at least one of the following steps: (a) obtaining the envelope in which the opening further comprises at least one sound attenuating means configured to muffle the sound passing through the opening, and muffling at least partially the sound; (b) obtaining the envelope in which the opening is adapted by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, passing at least a portion of the equipment form the environment to the inner volume; and, (c) obtaining the envelope in which the opening is adapted by means of size and shape to allow passage of a handler's hand, and reversibly passing a handler's hand through the opening.
- a method as defined above additionally comprising a step of configuring the envelope to providing at least one open position for accommodating the patient, and at least one closed position for to at least partially confining the patient within the inner volume, and accommodating or confining the patient.
- a method as defined above is disclosed, additionally comprising a step of securing the closed position of the envelope by means of such as a lock, bar, belt, pin, hook, and etc.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising a quick release mechanism enabling rapid access to a patient within the inner volume, and operating the quick release mechanism.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least a portion of at least partially transparent material, wherein the transparent material enables at least a part of the patient to be observed visually, and viewing the patient.
- a method as defined above additionally comprising at least one of the following steps: (a) obtaining the envelope further configured to separating patient tissues from coming into contact with the MRD bore; (b) obtaining the envelope further comprising the inner volume facing shape selected from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) obtaining the envelope further defined by means of size and shape for enabling the placement of the patient's body such that the body does not form electrically conducting loops.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least one sensor configured to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof, and sensing by the sensor.
- a method as defined above is disclosed, additionally comprising a step of coupling equipment such as medical, electrical, data transferring, lighting, monitoring, heating, ventilating, viewing, etc. to the PTI.
- equipment such as medical, electrical, data transferring, lighting, monitoring, heating, ventilating, viewing, etc.
- a method as defined above is disclosed, additionally comprising a step of receiving input from user interface, enabling surveillance of the patient.
- a method as defined above is disclosed, additionally comprising a step of quick releasing the MRI-compatible neonate's cradle from the PTI following need.
- a method as defined above additionally comprising a step of obtaining the envelope further configured to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof, and reversibly connect at least one aid module.
- a reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof, and reversibly connect at least one aid module.
- a method as defined above additionally comprising a step of connecting at least one reversibly connectable module at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a method as defined above additionally comprising a step of configuring the PTI to reduce the noise within the inner volume, in a predefined sound characteristic selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a method as defined above additionally comprising a step of reducing the noise within the inner volume, by at least one selected from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a method as defined above additionally comprising a step of changing at least one sound characteristic reaching the inner volume from the environment, selected from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof, thereby generating at least one sound signature.
- a method as defined above additionally comprising a step of selecting the sound signature from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the neonate's life parameters, and any combination thereof.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least one selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, an active sound cancellation device, and any combination thereof, configured to change the sound signature reaching the patient.
- a method as defined above additionally comprising a step of obtaining the envelope further comprising at least a portion of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a method as defined above additionally comprising a step of obtaining the envelope in which at least a portion comprising n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a method as defined above additionally comprising a step of obtaining the envelope comprising n layers, each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further selecting each the layer comprising equal or different the NRC value, STC value, or both, for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a method as defined above additionally comprising a step of obtaining the envelope comprising the n layers further comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- NRC Noise Reduction Coefficient
- a method as defined above additionally comprising a step of obtaining the envelope comprising the n layers further comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - . . ASn, wherein dS of the PTI equals Si - Sn, and Si-Sn ⁇ Si.
- STC Sound transmission class
- a method as defined above additionally comprising a step of obtaining the envelope further comprising: (a) a space, Si -n, between at least two the of n layers; (b) STCi (sound transmission class) value, measured for the layers i -n ; and, (c) reversible mobilization means, connected to at least one of the n layers, configured to mobilize at least one of the n layers, having a space Si -n between at least two of n layers such that a space S ⁇ a i S , and STC 2 value measured for the layers i -n are provided; where Si -n ⁇ Si n;a and where STCi ⁇ STC 2 , and reversibly mobilizing at least one layers.
- a method as defined above additionally comprising a step of obtaining the envelope further configured to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of utilizing at least one selected from a group consisting of: absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, and any combination thereof.
- a method as defined above additionally comprising the following steps: (a) obtaining the envelope further characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; the PTI further comprising in at least one of the ends, a temperature regulating vent (TRV); the TRV is adapted to stream air from the end towards the opposite end substantially along the axis; and is configured, by means of size and shape, to accommodate the patient in parallel to the axis; (b) selecting the TRV from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof; and, (c) operating the TRV, thereby preforming at least one of the following: venting, heating, cooling, filtering, humidifying, the air within the inner volume.
- TRV temperature regulating vent
- a method of manufacturing a patient transport incubator (PTI) suitable for MRI device having an open bore comprising an inner volume having a first set of dimensions, adapted by means of shape and size to accommodate at least a portion of an MRI-compatible neonate's cradle, the inner volume is further covered by an envelope having a second set of dimensions, adapted by means of shape and size to be temporarily introduced within the open bore; wherein at least a portion of the envelope comprises MRI safe thermo-isolating and noise reducing foam, comprising steps of: (a) defining dimensions of inner volume to accommodate at least a portion of the MRI-compatible neonate's cradle; (b) defining dimension adapted by shape and size for the envelope to be temporarily introduced within the MRI open bore when accommodating at least a portion of the MRI compatible neonate's cradle; and (c) forming the envelope separating inner volume from its environment; wherein at least a portion of the envelope comprises MRI safe, thermo-isolating,
- a method as defined above is disclosed, additionally comprising a step of forming at least a portion of the envelope is integrated with fire retardant materials.
- a method as defined above is disclosed, additionally comprising a step of forming the envelope comprising at least one opening.
- a method as defined above additionally comprising a step of, wherein at least one of the following holds true: (a) attaching at least one sound attenuating means configured to muffle the sound passing through the opening; (b) adapting the opening by means of size and shape for the passage of equipment selected from a group consisting of: tubing, life supporting, monitoring, sensing, temperature maintaining, ventilating and any combination thereof; and, (d) configuring the opening by means of size and shape to allow passage of a handler's hand.
- a method as defined above additionally comprising a step of configuring the envelope for at least one open position for accommodating the patient, and at least one closed position for at least partially confining the patient within the inner volume.
- a method as defined above is disclosed, additionally comprising a step of attaching a quick release mechanism enabling rapid access to a patient within the inner volume.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope comprising at least partially transparent material, thereby enabling at least a part of the patient to be observed visually.
- a method as defined above additionally comprising a step of, wherein at least one of the following holds true: (a) forming the envelope configured to separating the patient tissues from coming into contact with the MRD bore; (b) selecting the envelope inner volume facing shape from a group consisting of: patient ergonomic, none ergonomic, patient movement restrictive shape, and any combination thereof; and, (c) defining the envelope by means of size and shape for enabling placement of the patient's body such that the body does not form electrically conducting loops.
- a method as defined above additionally comprising a step of attaching at least one sensor to the envelope, and configuring the sensor to sense at least one parameter selected from a group consisting of: temperature, humidity, 0 2 concentration, C0 2 concentration, 0 2 concentration, sound level, sound frequency, sound direction, sound amplitude, sound tone, sound speed, vibration, movement, drift, light, PTI configuration, PTI structural integrity, PTI lock configuration and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of connecting at least two parts in order to form the envelope separating inner volume from its environment.
- a method as defined above is disclosed, additionally comprising a step of defining the dimensions of the envelope parts to be adapted to be ergonomic to the handler.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope foam by means selected from a group consisting of: open-molding, closed-molding injection, vacuum forming, extruding, expanding, casting, stretching, sheet assembling, foaming, compositing and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of further forming at least a part of the envelope by surface modifications such as cleaning, sterilizing, smoothing, adding texture, coloring, covering, typing, adhering, puncturing, hammering, spraying, immersing, etc.
- a method as defined above additionally comprising a step of creating a space fitting by dimensions of size and shape to permit passage of equipment selected from a group of: medical, electrical, data transferring, sensing, ventilating, heating, viewing, monitoring and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of defining the connection areas between the envelope by means of location, material, shape and size to isolate the inner volume of the envelope from the outside conditions such as temperature, humidity, sound, vibration, etc.
- a method as defined above is disclosed, additionally comprising a step of including at least one user interface.
- a method as defined above is disclosed, additionally comprising a step of constructing a separate module of user interface.
- a method as defined above is disclosed, additionally comprising a step of connecting sensing equipment from a selected group consisting of: temperature, humidity, gas concentrations, sound levels, vibrations, drift, light, respiration, cardiac function, blood oxygenation, neurological activity, electricity, radio frequency, data transfer, opened or closed state of incubator envelope, structural integrity of incubator, structural integrity of interconnected parts, general function of incubator and any combination thereof to the incubator .
- a method as defined above additionally comprising a step of connecting user interface to an item selected from a group consisting of: medical equipment, sensing equipment, electrical equipment, monitoring equipment, control unit, CPU, audio indicator, visual indicator, sensing indicator, alarm system, power supply and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of integrating a quick release mechanism enabling rapid access to the MRI-compatible neonate's cradle within inner volume.
- a method as defined above additionally comprising a step of configuring the envelope to house at least one reversibly connectable module selected from a group consisting of: a temperature regulating vent module, a venting module, a user interface module, a control unit module, at least one life support system module, a monitoring module, a sensor module, and any combination thereof.
- a method as defined above additionally comprising a step of creating at least one reversible connection for at a location, relative to the envelope, selected from a group consisting of: top, bottom, side, back, front and any combination thereof.
- a method as defined above additionally comprising a step of configuring the PTI to reduce the noise within the inner volume, in a predefined sound characteristic, and selecting the sound characteristic from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof.
- a method as defined above is disclosed, additionally comprising a step of selecting at least one noise parameter to be reduced from a group consisting of: sound level reduction, sound reflections reduction, sound reverberation reduction, sound diffusion, altered sound signature, and any combination thereof.
- a method as defined above additionally comprising a step of selecting at least one sound characteristic reaching the inner volume from the environment from a group consisting of: sound levels, tone, overtone composition, reverberations, sound frequency, sound wavelength, sound wave amplitude, sound wave speed, sound wave direction, sound wave energy, sound wave phase, sound wave shape, sound wave envelope, sound timbre, and any combination thereof, thereby generating at least one sound signature, to be changed by the PTI.
- a method as defined above additionally comprising a step of selecting the sound signature from a group consisting of: configurable by the user, predefined, automatically adjustable in reference to the patient's life parameters, and any combination thereof.
- a method as defined above additionally comprising a step of including at least one means selected from a group consisting of: a sound absorptive material, a resonator, a sound shield, a bass trap, a sound baffle, a diffuser, an insulation padding, a sound reflector, a sound muffler, and any combination thereof, configured to changing the sound signature reaching the patient.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope of a material selected from a group consisting of: at least one sealing material, at least one sound absorbent material, at least one vibration absorbing material, and any combination thereof.
- a method as defined above additionally comprising a step of forming at least a portion of the envelope comprising n layers; further wherein each of the n layers comprising an inner side towards the inner volume, and an opposite outer side facing towards the environment.
- a method as defined above additionally comprising a step of forming each of the n layers comprising a predefined Noise Reduction Coefficient (NRC) value, Sound Transmission Class (STC) value, or both; further wherein the NRC value, STC value, or both, can be equal or different for the each of one of n layers.
- NRC Noise Reduction Coefficient
- STC Sound Transmission Class
- a method as defined above additionally comprising a step of forming the n layers comprising a Noise Reduction Coefficient (NRC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured on the layer inner side, having a dSi - ... dSn, wherein dS of the PTI equals
- NRC Noise Reduction Coefficient
- a method as defined above additionally comprising a step of forming the n layers comprising a Sound transmission class (STC) value for each of the n layers; where each of the layers comprising at least one sound level Si [dB] measured on the layer outer side, and at least one first sound level S n [dB], measured the layer inner side, having a dSi - ...dS «, wherein dS of the PTI equals Si - Sn,
- STC Sound transmission class
- a method as defined above additionally comprising the following steps: (a) forming the envelope further comprising a space, Si-n , between at least two the of n layers; (b) configuring at least one STCi (sound transmission class) value, measured for the layers i -n ; and, (c) connecting reversible mobilization means, connected to at least one of the n layers, configured to mobilizing at least one of the n layers, having a space Si -n between at least two of n layers such that a space Si- n, a is, and STC 2 value measured for the layers i -n are provided; where Si -n ⁇ Sin ,a and where
- a method as defined above additionally comprising a step of configuring the envelope to reduce reverberation of sound, reflections of sound, or both within the inner volume, by means of at least one selected from a group consisting of; absorptive material, a sound baffle, a sound diffuser, a sound resonator, a sound shield, an active sound cancellation device and any combination thereof.
- a method as defined above additionally comprising the following steps: (a) a step of forming the envelope further characterized by an elongated shape, having a main longitudinal axis with a proximal end and an opposite distal end; (b) connecting a temperature regulating vent (TRV) to the PTI in at least one of the ends; (c) configuring the TRV to stream air from the end towards the opposite end substantially along the axis; (d) configuring the envelope, by means of size and shape, to accommodate the patient in parallel to the axis; and, (e) selecting the TRV from a group consisting of at least one first venting module, at least one first heating/cooling module, at least one filter located adjacently to either the first venting module or the first heating/cooling module, at least one humidifying module and any combination thereof.
- TRV temperature regulating vent
- a standard of care protocol for MRI of patients comprising steps of: (a) obtaining a PTI suitable for magnetic resonance imaging device (MRD) with an open bore, the incubator comprising an inner volume having a first set of dimensions, the inner volume is adapted by means of shape and size to accommodating at least a portion of the MRI-compatible neonate's cradle, the inner volume further is covered by an envelope having a second set of dimensions, adapted by shape and size to be temporarily introduced within the open bore; when at least a portion of the envelope comprises MRI-safe thermo-isolating and noise reducing foam, confining the compartment from its environment; (b) placing the patient into the MRI-compatible neonate's cradle; (c) at least partially accommodating the MRI-compatible neonate's cradle by the PTI enveloped inner volume; and, (d) introducing the PTI accommodating the MRI-compatible neonate's cradle into MRI open bore and imaging; wherein at least one of the following is
- the PTI will continue to be used safely in occurrence of a leakage of up to 200 ml deposited in the compartment of the PTI; (j) the PTI will remain stable when tilted 10° in normal use and when tilted 20° during transportation;(k) the PTI will not tip over when the force is 100 N or less;(l) the average number of patients MRI related fall incidents when utilizing the PTI is r times lower than the average of patients MRI related fall incidents; r is equal or greater than 1.05; (m) the average number of patient infections acquired that is MRI associated, when utilizing the PTI, is s times lower than the average number of infections acquired by patients that is MRI associated; sis equal or greater than 1.05; (n) the average number of MRI associated patient's health complications when utilizing the PTI is t times lower than the
- the patient transport incubator includes a cylindered shaped enclosure (100) having at least two parts. At least a portion of the envelope enclosure comprises a thickened MRI permeable, non-interfering, safe foam layer (20).
- the envelope has an opening (30) allowing for an opened and closed configuration of the incubator, wherein the opened configuration enables placement of the patient.
- the envelope further is comprised from at least a portion of transparent material (10) enabling view of at least part of the patient.
- the envelope further has openings (52-57) that permit passage through or connection of a plurality of equipment dedicated to maintain, monitor, and control the patient status and incubator status.
- This equipment includes devices dedicated for medical supporting, monitoring, lighting, heating, viewing, ventilating, etc.
- sensing equipment of the physical properties of the transport incubator and the inner volume such as temperature, humidity, gas concentration, vibration, sound level, drift, structural integrity, open or closed configuration, etc.
- the transport incubator further harbors a user interface space (50) were the connections and pass-through elements are organized.
- the user interface may also include indicators (51) such as visible, auditable, and sensible that respond to data from the sensing equipment of the incubator, and of the patient.
- the user interface is located at the front of the infant transport incubator so it is accessible when the incubator is inside MRD open bore.
- the PTI having all means for standing all applied regulations, especially the following standards and sections thereof: ANSI/AAMI/IEC 60601-2-20:2009 medical electrical equipment - part 2-20: particular requirements for the basic safety and essential performance of infant transport incubators; and more specifically to section 201.3.201; air controlled transport incubator in which the air temperature is automatically controlled by an air temperature sensor close to a value set by the operator; 201.3.202 average temperature average of temperature readings taken at regular intervals at any specified point in the compartment achieved during steady temperature condition; 201.3.203 average transport incubator temperature average of the infant transport incubator temperature readings taken at regular intervals achieved during steady temperature condition; 201.3.204 baby controlled transport incubator air controlled transport incubator which has the additional capability of automatically controlling the incubator air temperature in order to maintain the temperature as measured by a skin temperature sensor according to the control temperature set by the operator note an infant transport incubator operating as a baby controlled incubator is a physiologic closed-loop controller as defined in IEC 60601-1- 10.; 201.3.205 compartment environmentally-controlled enclosure intended to
- FIG. IB schematically illustrating, in an out of scale manner, a cross section view of an embodiment of the invention along the line of A in Fig. 1A.
- An infant transport incubator configured in a cylindered embodiment (100), comprising an envelope fitted to accommodate patient.
- the envelope shape is concave, and defined to fit the overall shape of the patient head (21).
- This envelope is provided in a plurality of dimensions and shapes to accommodate different needs: different patient sizes, providing a movement restricting space, ergonomic placement, a placement for the patient body arranged so it does not form conducting loops, fitting specific patient body position, etc.
- Fig.2A schematically illustrating, in an out of scale manner, an embodiment of the invention in a rectangular form (100).
- the patient transport incubator is connected to a detachable multi-use user interface module (80) whereas the rest of the envelope is disposable.
- FIG.2B schematically illustrating, in an out of scale manner, a cross section view of an embodiment of the invention along the line of A in Fig.2A, showing a solid MRI safe foam layer (20), a partly concave envelope shape (21) and a transparent portion of the envelope (10).
- Fig.2C schematically illustrating, in an out of scale manner, an embodiment of the invention of a detachable user interface (80), harboring a handle for easy placement (81).
- the user interface includes: connections to medical and sensing devices (59), pass-through elements (52) for tubes (200), wires, etc., CPU (54) integrating analyzing and transmitting the data received from medical and sensing equipment, control unit of set equipment (53), indicators for the data received from sensing and medical equipment and from CPU (51), power supply (58) that is internally supplied DC, externally supplied AC or DC or both, an alarm system harboring indicators (visual, audible, sensible).
- FIG. 2D schematically illustrating, in an out of scale manner, a cross section view of a rectangular embodiment (100) of the invention, along the line of C in Fig. 2, describing another embodiment of a partly concaved envelope formed in an ergonomic shape (15).
- Fig.2E schematically illustrating, in an out of scale manner, a cross section view of a rectangular embodiment (100) of the invention, along the line of D in Fig. 2, presenting the arrangement of an embodiment of the incubator in a multilayer construction.
- a module of user interface (80) is interconnected to the front side of envelope.
- the envelope includes thermo-isolating MRI safe, preamble, foam adapted to fit patient ergonomically constructed of two parts: top (16) and bottom (15). Further envelope harbors another opening (22) for passage of equipment such as medical equipment, sensing equipment, etc, and a transparent portion (10).
- FIG.3 schematically illustrating, in an out of scale manner, an embodiment of the invention.
- a patient transport incubator (100) that includes another embodiment of an opening (30), and an attaching mechanism (42) that connect the PTI to the placement of the patient in the MRD bore.
- the attaching mechanism connects to a designated location in the incubator (40-41) on one side, the MRD on the other side.
- FIG.4A schematically illustrating, in an out of scale manner, an embodiment of the invention.
- a PTI in a cylindered embodiment (100) described as constructed of a top part (60) and bottom part (70) whereas each part is cast in one piece, and assembled together with a user interface (50) module (80).
- the top and bottom parts can be configured to have an opened or closed configuration further secured by a lock apparatus (90) so that the incubator does not change configuration due to patient's movements.
- this secure mechanism includes a fast release mechanism. This fast release mechanism provides immediate access to the patient in case of need.
- FIG.4B schematically illustrating, in an out of scale manner, a cross section view of a cylindrical embodiment (100) of the invention, along the line of A in Fig.4, describing the arrangement of the incubator embodied in Fig. 4A.
- FIG. 5 A schematic diagram illustrating, in an out of scale manner, the temperature measured across one section of the envelope of infant transport incubator, demonstrating the temperature inside the envelope is higher than the temperature measured on the outside.
- FIG. 6 A schematic diagram illustrating, ,in an out of scale manner, the sound level across one section of the envelope of infant transport incubator, demonstrating that the sound levels within inner volume are lower than the sound levels outside the envelope.
- FIG. 7 A schematic diagram illustrating, in an out of scale manner, the temperature as a function of time at an axis of a cross section of the foamed envelope. The temperature is measured both within the envelope of infant transport incubator, and outside the envelope. This diagram demonstrates that the change of the outside temperature does not reflect to the same extent on the temperature of the incubator's inner volume.
- Fig. 8 schematically illustrating, in an out of scale manner, an embodiment of the invention.
- the PTI (100) in an elongated configuration is connected to a thermo-regulating vent (600) at one end.
- the PTI further includes a disposable foam mattress (15) and a transparent portion enabling patient view (10).
- Fig. 9 schematically illustrating, in an out of scale manner, an embodiment of the invention.
- the PTI (100) in an elongated configuration, comprising a multi-layered construction (300).
- the layers are of the same or different shape, width, length, size, material NRC, STC, noise absorption, thermal conductivity, thermal capacity, sound refractive quality, and etc.
- the PTI's inner volume is adapted to fit, by means of size and shape, a MRI safe neonate incubator (710). Further in this embodiment the neonate incubator is attached to a MRI cart (700), while the assembly of the PTI encapsulating the infant incubator is designed to fit within the MRD open bore. Further this embodiment. At least a portion of the envelope enclosing the inner volume is made of thermo-regulating foam. This envelope has an opening (30), providing rapid, one step access to the incubator inside. At least a portion of the envelope is made of transparent material (10) enabling view of at least a part of neonate placed within.
- the PTI (100) is configured to cover an infant incubator (710) attached to an MRI cart (700), as a canopy. Additionally, this canopy includes a transparent portion (10) enabling view of at least a part of the infant.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pediatric Medicine (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19151693.9A EP3517032A1 (fr) | 2013-11-03 | 2014-11-03 | Incubateur de transport de patients en mousse |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361899233P | 2013-11-03 | 2013-11-03 | |
DE201320104934 DE202013104934U1 (de) | 2013-11-03 | 2013-11-04 | Patiententransportinkubator |
PCT/IL2014/050948 WO2015063774A2 (fr) | 2013-11-03 | 2014-11-03 | Couveuse en mousse expansée utilisable pour le transport de patients |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19151693.9A Division EP3517032A1 (fr) | 2013-11-03 | 2014-11-03 | Incubateur de transport de patients en mousse |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3062699A2 true EP3062699A2 (fr) | 2016-09-07 |
EP3062699A4 EP3062699A4 (fr) | 2017-07-19 |
EP3062699B1 EP3062699B1 (fr) | 2019-01-16 |
Family
ID=49781063
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19151693.9A Withdrawn EP3517032A1 (fr) | 2013-11-03 | 2014-11-03 | Incubateur de transport de patients en mousse |
EP14859025.0A Active EP3062699B1 (fr) | 2013-11-03 | 2014-11-03 | Couveuse en mousse expansée utilisable pour le transport de patients |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19151693.9A Withdrawn EP3517032A1 (fr) | 2013-11-03 | 2014-11-03 | Incubateur de transport de patients en mousse |
Country Status (6)
Country | Link |
---|---|
US (2) | US9974705B2 (fr) |
EP (2) | EP3517032A1 (fr) |
JP (1) | JP6673825B2 (fr) |
CN (1) | CN105873554B (fr) |
DE (1) | DE202013104934U1 (fr) |
WO (1) | WO2015063774A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL226488A (en) | 2013-05-21 | 2016-07-31 | Aspect Imaging Ltd | Baby crib |
US11278461B2 (en) | 2010-07-07 | 2022-03-22 | Aspect Imaging Ltd. | Devices and methods for a neonate incubator, capsule and cart |
US10076266B2 (en) | 2010-07-07 | 2018-09-18 | Aspect Imaging Ltd. | Devices and methods for a neonate incubator, capsule and cart |
US10794975B2 (en) | 2010-09-16 | 2020-10-06 | Aspect Imaging Ltd. | RF shielding channel in MRI-incubator's closure assembly |
US9597246B2 (en) | 2010-09-16 | 2017-03-21 | Aspect Imaging Ltd. | Premature neonate closed life support system |
US10292617B2 (en) | 2010-09-30 | 2019-05-21 | Aspect Imaging Ltd. | Automated tuning and frequency matching with motor movement of RF coil in a magnetic resonance laboratory animal handling system |
CN105682633B (zh) | 2013-09-02 | 2018-11-02 | 阿斯派克影像有限公司 | 有源热调节新生儿可运输保育箱 |
US10386432B2 (en) | 2013-12-18 | 2019-08-20 | Aspect Imaging Ltd. | Radiofrequency shielding conduit in a door or a doorframe of a magnetic resonance imaging room |
DE202015100024U1 (de) | 2014-01-29 | 2015-03-19 | Aspect Imaging Ltd. | Mittel zum Betreiben einer MRT-Vorrichtung in einer HF-magnetischen Umgebung |
WO2015173817A2 (fr) | 2014-05-13 | 2015-11-19 | Aspect Imaging Ltd. | Gaines de protection et d'immobilisation dotées de capteurs, et procédés permettant de réduire l'effet du mouvement de l'objet pendant le balayage d'irm |
GB201410442D0 (en) * | 2014-06-11 | 2014-07-23 | Roberts James | Inflatable child incubator |
US11300531B2 (en) | 2014-06-25 | 2022-04-12 | Aspect Ai Ltd. | Accurate water cut measurement |
EP3349710A1 (fr) * | 2015-09-15 | 2018-07-25 | Koninklijke Philips N.V. | Procédé et appareil pour soins néonatals améliorés |
US10224135B2 (en) | 2016-08-08 | 2019-03-05 | Aspect Imaging Ltd. | Device, system and method for obtaining a magnetic measurement with permanent magnets |
US11287497B2 (en) | 2016-08-08 | 2022-03-29 | Aspect Imaging Ltd. | Device, system and method for obtaining a magnetic measurement with permanent magnets |
US11988730B2 (en) | 2016-08-08 | 2024-05-21 | Aspect Imaging Ltd. | Device, system and method for obtaining a magnetic measurement with permanent magnets |
CN106074037B (zh) * | 2016-08-23 | 2018-08-14 | 刘秀霞 | 一种儿科护理病床 |
US20180160819A1 (en) * | 2016-12-12 | 2018-06-14 | Helene F. RUTLEDGE | Sleep pod with controlled environment |
US10345251B2 (en) | 2017-02-23 | 2019-07-09 | Aspect Imaging Ltd. | Portable NMR device for detecting an oil concentration in water |
US11052016B2 (en) | 2018-01-18 | 2021-07-06 | Aspect Imaging Ltd. | Devices, systems and methods for reducing motion artifacts during imaging of a neonate |
US11364167B2 (en) * | 2019-02-12 | 2022-06-21 | GE Precision Healthcare LLC | Neonatal care system with sling sleep device |
CN109907920A (zh) * | 2019-04-25 | 2019-06-21 | 朱丽丽 | 一种自适应中医推拿针灸用保温系统 |
CN110946580B (zh) * | 2019-11-06 | 2023-06-09 | 中国人民解放军陆军军医大学第一附属医院 | 核磁共振检测系统 |
DE102019218895B4 (de) * | 2019-12-04 | 2024-07-25 | Siemens Healthineers Ag | Wärmebettvorrichtung, eine Magnetresonanzvorrichtung mit einer Wärmebettvorrichtung, sowie ein Verfahren zu einem Überwachen einer Temperatur einer Wärmebettvorrichtung während einer Magnetresonanzuntersuchung |
CN111467166A (zh) * | 2020-05-12 | 2020-07-31 | 邓益群 | 一种微压生态大气舱 |
CN113081593B (zh) * | 2021-03-10 | 2022-07-01 | 何君品 | 降噪密闭舱及呼吸辅助系统 |
Family Cites Families (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1900342A (en) | 1929-08-03 | 1933-03-07 | Julius H Hess | Infant incubator |
US2638087A (en) | 1949-10-18 | 1953-05-12 | Livsey Ralph | Infant incubator |
US2708927A (en) | 1952-11-21 | 1955-05-24 | Continental Hospital Service I | Incubator for infants |
US3012836A (en) | 1957-04-23 | 1961-12-12 | Shampaine Ind Inc | Incubators for infants |
US3315671A (en) | 1965-03-17 | 1967-04-25 | Raymond C Creelman | Child-restraining device for physician's use |
US3470866A (en) | 1966-11-16 | 1969-10-07 | Stanley B Gittelson | Portable incubator |
US3655178A (en) | 1968-04-12 | 1972-04-11 | Jean A Vezina Ltee Entreprises | Pediatric device for immobilizing a patient-child |
US3710791A (en) | 1970-03-09 | 1973-01-16 | Ahldea Corp | Inflatable patient enclosures |
US3920000A (en) | 1974-05-22 | 1975-11-18 | Harry D Atherton | Temperature controller for incubators |
US4121571A (en) | 1977-01-28 | 1978-10-24 | Pickering Donald E | Transportable life support chamber, method and system |
FR2522963A1 (fr) | 1982-03-12 | 1983-09-16 | Calhene | Installation pour le confinement et le transport en atmosphere sterile d'etres humains, notamment de nouveau-nes |
IL75215A (en) | 1985-05-16 | 1992-07-15 | Israel Atomic Energy Comm | Infant incubator |
US4712263A (en) | 1986-12-24 | 1987-12-15 | Catherine Pronzinski | Neonatal blanket |
US4936824A (en) | 1987-05-15 | 1990-06-26 | The Boc Group, Inc. | Infant incubator with air curtain |
US5059906A (en) | 1988-11-25 | 1991-10-22 | Kabushiki Kaisha Toshiba | Magnetic resonance imaging apparatus |
DE4008822A1 (de) | 1990-03-20 | 1991-09-26 | Draegerwerk Ag | Inkubator mit gleichmaessiger luftfuehrung |
US5446934A (en) | 1993-11-30 | 1995-09-05 | Frazier; Richard K. | Baby monitoring apparatus |
US6709384B1 (en) | 1993-12-17 | 2004-03-23 | Hill-Rom Services, Inc. | Infant thermal support device |
US5759149A (en) | 1993-12-17 | 1998-06-02 | Hill-Rom, Inc. | Patient thermal support device |
US5817003A (en) | 1993-12-17 | 1998-10-06 | Hill-Rom, Inc. | Controller for a patient warming device |
US5534669A (en) | 1994-11-14 | 1996-07-09 | Schroeder; Jeff | Transportable incubator chamber for human and zoological applications |
US5971913A (en) | 1995-09-25 | 1999-10-26 | Hill-Rom, Inc. | Noise and light monitor apparatus |
JPH09285505A (ja) | 1996-04-19 | 1997-11-04 | Atom Medical Kk | 保育器 |
DE19617739C1 (de) | 1996-05-03 | 1997-06-12 | Draegerwerk Ag | Inkubator für tomographische Untersuchungen |
USRE38453E1 (en) | 1996-08-27 | 2004-03-09 | Hill-Rom Services, Inc. | Infant incubator |
WO1998048756A1 (fr) | 1997-04-25 | 1998-11-05 | Bo Nordell | Systeme incubateur destine a une utilisation en imagerie par resonance magnetique |
NO309224B1 (no) | 1997-10-29 | 2001-01-02 | Torgeir Hamsund | Kuvöse |
US6155970A (en) | 1998-07-20 | 2000-12-05 | Datex-Ohmeda, Inc. | Rotating infant mattress |
GB2340219B (en) | 1998-07-29 | 2000-10-11 | Chu Yun Yuan | Air conditioned bed hood apparatus |
WO2000033722A2 (fr) | 1998-12-08 | 2000-06-15 | Odin Medical Technologies Ltd | Procede et systeme permettant de deplacer et de positionner une soude d'irm ouverte |
US6231499B1 (en) | 1999-05-21 | 2001-05-15 | Datex-Ohmeda, Inc. | Lift mechanism for infant care apparatus canopy |
US6317618B1 (en) | 1999-06-02 | 2001-11-13 | Odin Technologies Ltd. | Transportable intraoperative magnetic resonance imaging apparatus |
JP3549789B2 (ja) | 1999-11-26 | 2004-08-04 | ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー | Rfコイルおよび磁気共鳴撮影装置 |
US6471634B1 (en) | 1999-12-11 | 2002-10-29 | Datex-Ohmeda, Inc. | Infant care apparatus with bidirectional sliding drawer |
CA2326015A1 (fr) | 1999-12-11 | 2001-06-11 | Datex-Ohmeda, Inc. | Mecanisme de verrouillage de porte d'incubateur |
AU2489901A (en) | 2000-03-08 | 2001-09-13 | Fisher & Paykel Healthcare Limited | Radiant warmer |
USD446675S1 (en) * | 2000-07-31 | 2001-08-21 | Mariann C. Straub | Infant head positioner |
US6409654B1 (en) | 2000-08-15 | 2002-06-25 | Mcclain Anthony | Incubator system with monitoring and communicating capabilities |
CN2448344Y (zh) | 2000-10-30 | 2001-09-19 | 三丰医疗器材股份有限公司 | 婴儿保温箱的控制装置 |
US6684096B2 (en) * | 2000-12-15 | 2004-01-27 | Berndt P. Schmit | Restraining apparatus and method for use in imaging procedures |
ATE504875T1 (de) | 2001-02-06 | 2011-04-15 | Draeger Medical Infant Care Inc | Adaptive regelung der motordrehzahl in einem säuglingsinkubator |
CA2435543A1 (fr) | 2001-02-06 | 2002-08-15 | Hill-Rom Services, Inc. | Incubateur pediatrique avec detection et controle sans contact |
US7278962B2 (en) | 2001-04-12 | 2007-10-09 | Lmt Lammers Medical Technology Gmbh | Incubator for newborn and premature patients |
EP1379928B1 (fr) | 2001-04-16 | 2011-06-29 | Draeger Medical Systems, Inc. | Support pour bebe : systeme et procede de regulation thermique |
US6611702B2 (en) | 2001-05-21 | 2003-08-26 | General Electric Company | Apparatus for use in neonatal magnetic resonance imaging |
AU2002330199A1 (en) | 2001-10-05 | 2003-04-22 | Hill-Rom Services, Inc. | Patient-support apparatus having line management system |
EP1432374B1 (fr) * | 2001-10-05 | 2008-08-20 | Draeger Medical Systems, Inc. | Appareil de soins aux nourrissons |
AU2002332029A1 (en) | 2001-10-05 | 2003-04-22 | Hill-Rom Services, Inc. | Patient-support device and docking cart combination |
US6973689B2 (en) | 2001-11-14 | 2005-12-13 | Koninklijke Philips Electronics N.V. | Docking means for medical system comprising examination device and patient support device |
US6860272B2 (en) | 2002-01-17 | 2005-03-01 | Portal, Inc. | Device for immobilizing a patient and compressing a patient's skeleton, joints and spine during diagnostic procedures using an MRI unit, CT scan unit or x-ray unit |
US7693570B2 (en) | 2002-04-25 | 2010-04-06 | Fonar Corporation | Magnetic resonance imaging with adjustable fixture apparatus |
US6992486B2 (en) * | 2002-05-16 | 2006-01-31 | Advanced Imaging Research, Inc. | Radio frequency coil for resonance imaging analysis of pediatric patients |
PE20040074A1 (es) | 2002-07-12 | 2004-02-25 | Univ Pontificia Catolica Peru | Burbuja artificial neonatal |
US6699173B1 (en) | 2002-08-15 | 2004-03-02 | Datex Ohmeda, Inc. | Canopy seal for infant care apparatus |
DE10332787B4 (de) | 2003-07-02 | 2007-08-30 | Dräger Medical AG & Co. KG | Haube mit einer Doppelwand für ein Wärmetherapiegerät |
JP2005066320A (ja) * | 2003-08-01 | 2005-03-17 | Hitachi Medical Corp | 傾斜磁場コイル |
US20050038314A1 (en) | 2003-08-13 | 2005-02-17 | Falk Steven M. | Infrared communication with infant care apparatus |
US8147396B2 (en) | 2003-11-26 | 2012-04-03 | Advanced Imaging Research, Inc. | Neonate imaging sub-system |
US20060079730A1 (en) | 2004-10-13 | 2006-04-13 | Getsla Jane M | Cover for infant incubator |
DE102005004076A1 (de) | 2005-01-28 | 2006-08-10 | Dräger Medical AG & Co. KG | Wärmetherapiegerät |
CA2632100C (fr) | 2005-12-05 | 2013-11-26 | Scott M. Ahlman | Systeme a surface unique pour patient |
JP4825557B2 (ja) | 2006-03-24 | 2011-11-30 | 株式会社東芝 | 磁気共鳴イメージング装置及び磁気共鳴イメージング装置に用いられるコイルユニット |
US7599728B2 (en) | 2006-04-03 | 2009-10-06 | General Electric Company | Magnetic resonance imaging |
USD567948S1 (en) | 2006-06-26 | 2008-04-29 | Neil Tierney | Incubator for newborn infants |
US7850595B2 (en) * | 2007-01-08 | 2010-12-14 | White Robert D | Transferring and holding device for high-risk neonatal intensive care unit (NICU) patients |
WO2008137003A1 (fr) | 2007-04-30 | 2008-11-13 | Acentech, Inc. | Système d'atténuation de bruit acoustique pour un scanner par irm |
US9247346B2 (en) | 2007-12-07 | 2016-01-26 | Northern Illinois Research Foundation | Apparatus, system and method for noise cancellation and communication for incubators and related devices |
US8246531B2 (en) | 2007-12-19 | 2012-08-21 | Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon | Incubator for non-ionising radiation imaging |
JP5123082B2 (ja) | 2008-07-03 | 2013-01-16 | アトムメディカル株式会社 | 保育器におけるグロメット構造 |
US20110186049A1 (en) | 2008-08-12 | 2011-08-04 | Aspect Magnet Technologies Ltd. | A system for anesthetizing whilst attuning the temperature of mammals and methods thereof |
DE212009000105U1 (de) | 2008-09-10 | 2011-06-01 | Aspect Magnet Technologies Ltd. | Kammer für die Aufnahme von Tieren während anästhetischer Verfahren |
BRPI0804985B8 (pt) | 2008-11-14 | 2021-06-22 | Luiz Rodrigues Djalma | equipamento hospitalar, particularmente idealizado para o tratamento de neonatos |
WO2010071705A1 (fr) | 2008-12-16 | 2010-06-24 | Draeger Medical Systems, Inc. | Dispositif de thérapie par la chaleur comprenant un système de circulation d'air à deux canaux |
WO2010078395A2 (fr) | 2008-12-31 | 2010-07-08 | World Medical Technologies, Llc | Système modulaire de soin néonatal intensif |
IL196487A (en) | 2009-01-13 | 2016-03-31 | Aspect Imaging Ltd | Means for buying sharp resolution mri |
JP5295804B2 (ja) | 2009-02-04 | 2013-09-18 | 英伸 太田 | 保育器用フード、保育器および保育器システム |
EP2449412B1 (fr) | 2009-06-30 | 2019-04-24 | Aspect Imaging Ltd. | Dispositif à résonance magnétique avec ensembles d'aimants à l'intérieur d'une cage |
US9138366B2 (en) | 2009-08-26 | 2015-09-22 | Environmental Tectonics Corporation | Hyperbaric apparatus with storage compartment |
US20110113555A1 (en) | 2009-11-18 | 2011-05-19 | Smith Richard A | Apparatus to facilitate the transfer of patients between support platforms |
BR112012022314A2 (pt) | 2010-03-04 | 2017-10-03 | Biostek Eng Llc | Método e dispositivo para prover a uma incubadora de transporte neonatal portatil |
US20110234347A1 (en) | 2010-03-24 | 2011-09-29 | Aspect Magnet Technologies Ltd. | Pole piece for permanent magnet mri systems |
WO2012004797A2 (fr) * | 2010-07-07 | 2012-01-12 | Aspect Magnet Technologies Ltd. | Chambre de maintien des fonctions vitales à atmosphère contrôlée pour nouveau-nés prématurés destinée à être utilisée dans des dispositifs d'irm/de rmn |
IL226488A (en) | 2013-05-21 | 2016-07-31 | Aspect Imaging Ltd | Baby crib |
US9562956B2 (en) | 2012-10-31 | 2017-02-07 | Aspect Imaging Ltd. | Rotatable protective cover functioning as a door for MRI system |
US9597246B2 (en) | 2010-09-16 | 2017-03-21 | Aspect Imaging Ltd. | Premature neonate closed life support system |
DE202011051402U1 (de) | 2010-09-27 | 2011-11-25 | Aspect Magnet Technologies Ltd. | Mikrowells mit MRI lesbaren Markierungen |
DE202011050130U1 (de) | 2010-09-27 | 2011-08-01 | Aspect Magnet Technologies Ltd. | Maske für analysierte Säugetiere |
DE202011051413U1 (de) | 2010-09-29 | 2012-01-09 | Aspect Magnet Technologies Ltd. | Magnetresonanztomograf mit Magnetenanordnung zum praktischen Scannen von Versuchstieren |
US8807084B2 (en) | 2010-09-30 | 2014-08-19 | Aspect Imaging Ltd. | MRI device with a plurality of individually controllable entry ports and inserts therefor |
EP2640263A1 (fr) | 2010-11-16 | 2013-09-25 | Aspect Magnet Technologies Ltd. | Système et procédé de génération d'images invasivement hyperpolarisées |
CN103282007B (zh) | 2010-11-16 | 2015-11-25 | 婴儿潮医疗保健公司 | 一种恒温箱 |
US9116212B2 (en) | 2010-11-19 | 2015-08-25 | Siemens Aktiengesellschaft | Pediatric coil assembly |
DE212012000043U1 (de) | 2011-02-01 | 2013-09-06 | Aspect Magnet Technologies Ltd. | Niedrigfeld-Magnetresonanzsystem (LF-MRS) zum Erzeugen eines Magnetresonanzbildes |
WO2012143825A1 (fr) | 2011-04-18 | 2012-10-26 | Koninklijke Philips Electronics N.V. | Appareil d'irm comportant une bobine rf locale mobile par rapport à un support de patient pédiatrique |
US20130079624A1 (en) | 2011-09-23 | 2013-03-28 | Uri Rapoport | Graphical user interface for operating an mri |
EP2581071A1 (fr) | 2011-10-14 | 2013-04-17 | Universiteit Maastricht | Brancard pour ambulance comprenant un chariot et un support |
US20140003614A1 (en) | 2011-12-12 | 2014-01-02 | Alex Levitov | Neonatal incubator |
US20130150656A1 (en) | 2011-12-13 | 2013-06-13 | General Electric Company | Infant transporter apparatus |
CN202515672U (zh) * | 2012-01-11 | 2012-11-07 | 明峰医疗系统股份有限公司 | 同机架pet/mri扫描成像设备 |
CN102551978B (zh) * | 2012-01-19 | 2015-03-25 | 美时医疗技术(上海)有限公司 | 一种磁共振兼容婴儿培养箱 |
US9968279B2 (en) | 2012-02-02 | 2018-05-15 | Children's Hospital Medical Center | MRI transfer table assembly |
US10045712B2 (en) | 2012-02-02 | 2018-08-14 | Children's Hospital Medical Center | MRI transfer station and dock |
DE202012101227U1 (de) * | 2012-04-04 | 2012-07-11 | Aspect Magnet Technologies Ltd. | Verbessertes geschlossenes Lebenserhaltungssystem für Frühgeborene |
US9239366B2 (en) | 2012-06-06 | 2016-01-19 | Aspect Imaging Ltd. | High resolution high contrast MRI for flowing media |
JP5955654B2 (ja) | 2012-06-12 | 2016-07-20 | 東芝メディカルシステムズ株式会社 | 画像診断装置、x線コンピュータ断層撮影装置、医療用寝台装置、及び寝台制御方法 |
US9375187B2 (en) | 2012-06-19 | 2016-06-28 | Siemens Medical Solutions Usa, Inc. | Modular patient handling system for medical imaging apparatus |
US20140050827A1 (en) | 2012-08-15 | 2014-02-20 | Aspect Imaging Ltd. | Non-invasive mri system for analyzing quality of solid food products enveloped by flexible aluminum foil wrapper and methods thereof |
IL221491A (en) | 2012-08-15 | 2016-06-30 | Aspect Imaging Ltd | A magnetic resonance device integrated with a light field camera |
US20140051973A1 (en) | 2012-08-15 | 2014-02-20 | Aspect Imaging Ltd | Mri imaging system for generating a rendered image |
US20140051974A1 (en) | 2012-08-15 | 2014-02-20 | Aspect Imaging Ltd. | System and method for mri imaging using polarized light |
US9709652B2 (en) | 2012-10-07 | 2017-07-18 | Aspect Imaging Ltd. | MRI system with means to eliminate object movement whilst acquiring its image |
US20140128725A1 (en) | 2012-11-08 | 2014-05-08 | Aspect Imaging Ltd. | Neonate's incubator and mri docking-station |
US9864034B2 (en) | 2012-11-21 | 2018-01-09 | Aspect Imaging Ltd. | Method and system for a universal NMR/MRI console |
US20140142914A1 (en) | 2012-11-22 | 2014-05-22 | Aspect Imaging Ltd. | Means and methods of multidimensional modeling in vivo spatial image of an mri contrast agent |
US9551731B2 (en) | 2012-12-02 | 2017-01-24 | Aspect Imaging Ltd. | Gantry for mobilizing an MRI device towards static patients |
US20140152310A1 (en) | 2012-12-02 | 2014-06-05 | Aspect Imaging Ltd. | Gantry for mobilizing an mri device |
US20140230850A1 (en) | 2013-02-20 | 2014-08-21 | Aspect Imaging Ltd. | Ramrod for mri and methods thereof |
US9155490B2 (en) | 2013-03-07 | 2015-10-13 | Aspect Imaging Ltd. | Integrated stethoscope-metal detector device |
US9535141B2 (en) | 2013-03-13 | 2017-01-03 | Aspect Imaging Ltd. | MRI safety device means and methods thereof |
WO2014159951A1 (fr) | 2013-03-14 | 2014-10-02 | The Research Foundation For The State University Of New York | Couveuse pour bébé portable |
US20140300358A1 (en) | 2013-04-08 | 2014-10-09 | Aspect Imaging Ltd. | System and method for real-time noise reduction in mri data acquisition |
DE202013105901U1 (de) | 2013-09-02 | 2014-02-11 | Aspect Imaging Ltd. | Inkubator mit doppeltverglaster Wand |
DE202013105212U1 (de) | 2013-11-17 | 2013-12-19 | Aspect Imaging Ltd. | Schließvorrichtung eines MRT-Inkubators |
US10018692B2 (en) | 2013-11-20 | 2018-07-10 | Aspect Imaging Ltd. | Shutting assembly for closing an entrance of an MRI device |
-
2013
- 2013-11-04 DE DE201320104934 patent/DE202013104934U1/de not_active Expired - Lifetime
-
2014
- 2014-11-03 US US14/531,289 patent/US9974705B2/en active Active
- 2014-11-03 EP EP19151693.9A patent/EP3517032A1/fr not_active Withdrawn
- 2014-11-03 EP EP14859025.0A patent/EP3062699B1/fr active Active
- 2014-11-03 WO PCT/IL2014/050948 patent/WO2015063774A2/fr active Application Filing
- 2014-11-03 CN CN201480072145.0A patent/CN105873554B/zh active Active
- 2014-11-03 JP JP2016528129A patent/JP6673825B2/ja active Active
-
2018
- 2018-03-15 US US15/921,748 patent/US20180250181A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150126804A1 (en) | 2015-05-07 |
US9974705B2 (en) | 2018-05-22 |
WO2015063774A2 (fr) | 2015-05-07 |
JP2017501760A (ja) | 2017-01-19 |
EP3062699B1 (fr) | 2019-01-16 |
EP3062699A4 (fr) | 2017-07-19 |
EP3517032A1 (fr) | 2019-07-31 |
US20180250181A1 (en) | 2018-09-06 |
WO2015063774A3 (fr) | 2015-07-09 |
JP6673825B2 (ja) | 2020-03-25 |
DE202013104934U1 (de) | 2013-11-20 |
CN105873554B (zh) | 2019-04-05 |
CN105873554A (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180250181A1 (en) | Foamed patient transport incubator | |
US20160199241A1 (en) | Incubator with a noise muffling mechanism and method thereof | |
Wodicka et al. | A model of acoustic transmission in the respiratory system | |
US10796683B2 (en) | Active noise control microphone array | |
WO2008137003A1 (fr) | Système d'atténuation de bruit acoustique pour un scanner par irm | |
WO2019203089A1 (fr) | Structure d'insonorisation | |
Wubben et al. | The sound of operation and the acoustic attenuation of the Ohmeda Medical Giraffe OmniBedTM | |
WO2019138920A1 (fr) | Structure d'insonorisation, enceinte d'insonorisation et cellule d'insonorisation | |
Kellman | Noise in the intensive care nursery | |
Fasih-Ramandi et al. | Background noise in Iranian hospital intensive care units | |
EP4031087A1 (fr) | Support de régulation de bruit d'incubateur | |
US20220008277A1 (en) | Infant incubator | |
CN107334577A (zh) | 用于核磁共振检查的消音耳机 | |
JP2003020807A (ja) | 睡眠カプセル | |
CN207075964U (zh) | 一种带有报警系统的婴儿保育装置 | |
Muqowi et al. | The Use of Micro-structure Absorber for Dealing with Acoustic Preferences in ICU | |
JPH08326178A (ja) | 建材およびそれを用いた壁パネル |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160525 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170616 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 6/04 20060101ALI20170609BHEP Ipc: A61B 5/055 20060101AFI20170609BHEP Ipc: A61G 11/00 20060101ALI20170609BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180806 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014040169 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1089064 Country of ref document: AT Kind code of ref document: T Effective date: 20190215 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20190116 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1089064 Country of ref document: AT Kind code of ref document: T Effective date: 20190116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190516 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190416 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190516 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190417 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190416 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014040169 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
26N | No opposition filed |
Effective date: 20191017 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602014040169 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191130 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191103 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191130 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20191130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191103 Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191103 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200603 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20141103 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190116 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231123 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20231120 Year of fee payment: 10 |